Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ischemic Heart Disease
  Free Subscription

Articles published in
J Am Coll Cardiol
    January 2026
  1. SIMADER FA, Rajkumar CA, Foley MJ, Ahmed-Jushuf F, et al
    Association Between Age and PCI Effectiveness in Stable CAD: Secondary Analysis of ORBITA-2.
    J Am Coll Cardiol. 2026;87:253-265.
    >> Share

  2. AZZALINI L, Kearney K, Salisbury AC, Stone N, et al
    Early vs Late Staged PCI After Subintimal Tracking and Re-Entry for Chronic Total Occlusions: A Randomized Trial.
    J Am Coll Cardiol. 2026;87:286-293.
    >> Share

  3. TAO L, He X, Shen G, Wu M, et al
    Drug-Coated Balloon Angioplasty vs Up-Front Stenting for De Novo CAD: 3-Year Follow-Up of REC-CAGEFREE I Trial.
    J Am Coll Cardiol. 2026;87:312-329.
    >> Share

  4. HAHN JY, Choi KH, Song YB
    Early Aspirin Withdrawal After PCI: Not All Acute Coronary Syndromes Are Created Equal.
    J Am Coll Cardiol. 2026;87:309-311.
    >> Share

  5. COSTA F, Diaz-Exposito A, Garcia-Ruiz V, Larrubia-Valle JI, et al
    Intracoronary Fibrinolysis in STEMI: A Promising Concept That Still Misses the Target.
    J Am Coll Cardiol. 2026;87:249-252.
    >> Share

  6. KRAMER CM, Blackwell J, Jones SO 4th, Kenigsberg D, et al
    Cardiovascular ASCs: Transforming Cardiovascular Procedural Care Through High Value Ambulatory Models.
    J Am Coll Cardiol. 2026 Jan 21:S0735-1097(25)10566.
    >> Share

  7. MUNZEL T, Luscher T, Kramer CM, Churchwell K, et al
    Environmental Stressors and Cardiovascular Health: Acting Locally for Global Impact in a Changing World: A statement of the European Society of Cardiology, the American College of Cardiology, the American Heart Association, and the World Heart Federat
    J Am Coll Cardiol. 2026 Jan 20:S0735-1097(26)00078.
    >> Share

  8. DZIEWIERZ A, Bobrowska B, Zasada W, Siudak Z, et al
    From Pathophysiology to Etiology: A Call for Precise Diagnosis in Young Patients With Myocardial Infarction.
    J Am Coll Cardiol. 2026 Jan 14:S0735-1097(25)10411.
    >> Share

  9. MA T, Guo Z, Xue Y, Yuan H, et al
    Metabolic Dysfunction-Associated Steatotic Liver Disease and CKM Syndrome: The Role of the Liver in Cardiovascular Risk Stratification.
    J Am Coll Cardiol. 2026 Jan 14:S0735-1097(25)10412.
    >> Share

  10. WADHERA RK, Dhruva SS, Bikdeli B, Bonaca MP, et al
    Cardiovascular Statistics in the United States, 2026: JACC Stats.
    J Am Coll Cardiol. 2026 Jan 12:S0735-1097(25)10558.
    >> Share

  11. WADHERA RK, Waken RJ, Wang F, Figueroa JF, et al
    Hospitalizations and Mortality Among Medicare Beneficiaries at Cardiovascular Risk: Disruptions and Recovery From the COVID-19 Pandemic.
    J Am Coll Cardiol. 2026 Jan 9:S0735-1097(25)10338.
    >> Share

  12. ABUSHAMAT LA, Hamid A, Nambi V, Wu H, et al
    Reducing Cardiovascular Disease Risk in Obesity: An Unexpected But Welcome FOURIER Transformation.
    J Am Coll Cardiol. 2026 Jan 7:S0735-1097(25)10258.
    >> Share

  13. HUSSAIN SM, Bjurling J, Yu C, Tonkin AM, et al
    Loss of Y Chromosome and Major Cardiovascular Events in a Prospective Study of Older Men.
    J Am Coll Cardiol. 2026;87:36-45.
    >> Share

  14. HONIGBERG MC
    CHIP, LOY, and Other Clonal Hematopoiesis Subtypes in Cardiovascular Disease.
    J Am Coll Cardiol. 2026;87:49-51.
    >> Share

  15. LIBBY P, Nordan T, Chiu N, Oren O, et al
    Wondering Y: How Might Loss of the Y Chromosome Promote Cardiovascular Disease in Aging Men?
    J Am Coll Cardiol. 2026;87:46-48.
    >> Share

  16. KRUMHOLZ HM
    Older Patients and Cardiovascular Disease: At the Center of Care, on the Margins of Science.
    J Am Coll Cardiol. 2026;87:1-3.
    >> Share

    December 2025
  17. TARDO DT, Cortes-Canteli M, Fuster V, Sachdev PS, et al
    The Heart-Brain-Metabolism Axis in Cardiovascular and Neurologic Disease.
    J Am Coll Cardiol. 2025;86:2663-2686.
    >> Share

  18. KRAMER CM
    The Cardiovascular Imager of the Future.
    J Am Coll Cardiol. 2025 Dec 17:S0735-1097(25)10276.
    >> Share

  19. KANG YM, Giugliano RP, Keech AC, Lopez JAG, et al
    Obesity-Associated Cardiovascular Risk and Benefit From PCSK9 Inhibition: A Prespecified Analysis From FOURIER.
    J Am Coll Cardiol. 2025 Dec 10:S0735-1097(25)10005.
    >> Share

  20. GANATRA S, Barac A, Armenian S, Cambareri C, et al
    Diagnosis and Management of Cardiovascular Adverse Effects of Targeted Oncology Therapies: Bruton's Tyrosine Kinase, Immune Checkpoint, and Vascular Endothelial Growth Factor Inhibitors: 2025 ACC Concise Clinical Guidance: A Report of the American Col
    J Am Coll Cardiol. 2025 Dec 10:S0735-1097(25)09916.
    >> Share

  21. BOEDDINGHAUS J, Lopez-Ayala P, Thurston AJF, Lee KK, et al
    Cardiovascular Risk Across Myocardial Injury and Infarction Categories Using the Universal Definition: An Individual Patient-Level Data Meta-Analysis.
    J Am Coll Cardiol. 2025 Dec 10:S0735-1097(25)10348.
    >> Share

  22. DANILOV A, Duran-Luciano P, Yuan Y, De Oliveira Gomes D, et al
    Association of Lp(a) With Cardiovascular Disease and All-Cause Mortality in U.S. Hispanics and Latinos.
    J Am Coll Cardiol. 2025;86:2292-2310.
    >> Share

  23. HAKEEM A, Shah JA, Kumar R, Ali A, et al
    Twice-Daily Clopidogrel vs Ticagrelor to Reduce Short-Term Major Adverse Cardiovascular Events After Primary Percutaneous Coronary Intervention: The TADCLOT Trial.
    J Am Coll Cardiol. 2025;86:2330-2345.
    >> Share

  24. KOHSAKA S, Kumamaru H, Sawano M, Mori M, et al
    Nationwide Trends in Coronary Revascularization in Japan, 2017 to 2023: From Decline to Plateau.
    J Am Coll Cardiol. 2025;86:2391-2394.
    >> Share

  25. MORAN AE, Apeagyei AE, Shyong C, Elliott H, et al
    Global Development Assistance for Health Allocated to Cardiovascular Disease Control, 2015 to 2022.
    J Am Coll Cardiol. 2025;86:2388-2390.
    >> Share

  26. WILLIAMS KA SR, Aggarwal M, Agustina R, Dastmalchi LN, et al
    Nutrition and Front-of-Package Food Labeling as a Catalyst for Cardiovascular Health: 2025 ACC Concise Clinical Guidance: A Report of the American College of Cardiology Solution Set Oversight Committee.
    J Am Coll Cardiol. 2025 Dec 5:S0735-1097(25)10156.
    >> Share

  27. DAMLUJI AA, Nanna MG, Menon V
    Frailty in Cardiovascular Disease: Time for a Universal Definition!
    J Am Coll Cardiol. 2025 Dec 3:S0735-1097(25)10032.
    >> Share

  28. LONGENECKER CT
    Embracing Uncertainty: The Future of Cardiovascular Surveillance.
    J Am Coll Cardiol. 2025;86:2158-2160.
    >> Share

  29. SPATZ ES
    Confronting the Global Rise of Obesity and Cardiovascular Disease: The Role of GLP-1 RAs.
    J Am Coll Cardiol. 2025;86:2155-2157.
    >> Share

  30. YAN LL, Nguyen QN, Chen X, Bloomfield GS, et al
    Improving Global Cardiovascular Health by Integrating Primary and Community-Based Care.
    J Am Coll Cardiol. 2025;86:2151-2154.
    >> Share

  31. KHERA R
    Toward a Global Cardiovascular Mission Control: Reimagining Surveillance Through Artificial Intelligence and Digital Health.
    J Am Coll Cardiol. 2025;86:2148-2150.
    >> Share

  32. WITTENBERG RE, Onuma OK
    Adapting Cardiovascular Disease Data to Inform Policy Goals: Global to Local.
    J Am Coll Cardiol. 2025;86:2142-2144.
    >> Share

  33. BIKDELI B, Rashedi S, Pfeferman MB, Barco S, et al
    Venous Thromboembolism: Global Burden of Disease Estimates Are Missing a Common Cardiovascular Condition.
    J Am Coll Cardiol. 2025;86:2135-2138.
    >> Share

  34. SUD M, Marelli AJ, Schull MJ, Ko DT, et al
    Canadian Cardiovascular Care at a Crossroad: Universal But Unequal.
    J Am Coll Cardiol. 2025;86:2124-2126.
    >> Share

  35. AL-KINDI S, Dakhil Z, Alasnag M, Al Suwaidi J, et al
    Cardiovascular Disease in the Middle East and North Africa.
    J Am Coll Cardiol. 2025;86:2115-2117.
    >> Share

  36. THIRUVENGADAM R, Karthikeyan G
    Interpreting Cardiovascular Disease Burden for Low-Middle Income Countries: A Perspective From India.
    J Am Coll Cardiol. 2025;86:2112-2114.
    >> Share

  37. NAEEM U, Sheikh S, Khan UI, Hanif B, et al
    Pakistan's Growing Heartache: Finding Hope for Cardiovascular Health Amid Uncertainty.
    J Am Coll Cardiol. 2025;86:2109-2111.
    >> Share

  38. OKAMURA T, Hirata A
    Current Status of Cardiovascular Disease in Japan: Prevention Strategies, Future Challenges, and Fundamental Lessons.
    J Am Coll Cardiol. 2025;86:2106-2108.
    >> Share

  39. KRUMHOLZ HM
    The Global Burden of Cardiovascular Disease: Not Just a Mirror, But a Compass.
    J Am Coll Cardiol. 2025;86:2103-2105.
    >> Share

    November 2025
  40. YUAN H, Zhong W, Xu S, Zhong H, et al
    Data-Driven Insights Into LDL-C and Cardiovascular Mortality in China: Implications for Management Strategies.
    J Am Coll Cardiol. 2025 Nov 26:S0735-1097(25)09988.
    >> Share

  41. MOHAMMADNIA N, Xue L, Vestjens LTW, Uddin MM, et al
    Colchicine and Longitudinal Dynamics of Clonal Hematopoiesis: An Exploratory Substudy of the LoDoCo2 Trial.
    J Am Coll Cardiol. 2025;86:1983-1996.
    >> Share

  42. ROSENSON RS, Goonewardena SN
    Remnant Cholesterol and Cardiovascular Risk in Young Adults: Moving Beyond Low-Density Lipoprotein Cholesterol.
    J Am Coll Cardiol. 2025;86:2059-2061.
    >> Share

  43. JUNG HN, Heo JH, Kim MJ, Han KD, et al
    Remnant Cholesterol as an Independent Cardiovascular Risk Factor in Young Adults: An Age-Stratified Cohort Study.
    J Am Coll Cardiol. 2025;86:2047-2058.
    >> Share

  44. SPATZ ES
    30-Year Cardiovascular Risk in Comparison With Peers: An Effective Cue to Action?
    J Am Coll Cardiol. 2025;86:2028-2030.
    >> Share

  45. KRISHNAN V, Huang X, Zhang S, Shah NS, et al
    Age and Sex-Specific Percentiles of 30-Year Cardiovascular Disease Risk Based on the PREVENT Equations.
    J Am Coll Cardiol. 2025;86:2017-2027.
    >> Share

  46. RAZAVI AC, Blaha MJ, Sperling LS, Whelton SP, et al
    Lp(a) and Inflammation in Cardiovascular Disease: On the Horizon for Risk Assessment and Future Therapies.
    J Am Coll Cardiol. 2025;86:2014-2016.
    >> Share

  47. TARDIF JC, Dube MP
    Does Colchicine Reduce Both Inflammation and Clonal Hematopoiesis in Atherosclerotic Cardiovascular Disease?
    J Am Coll Cardiol. 2025;86:1997-1999.
    >> Share

  48. BALDASSARRE LA, Mendes LA, Blankstein R, Hahn RT, et al
    2025 ACC/AHA/ASE/ASNC/SCCT/SCMR Advanced Training Statement on Advanced Cardiovascular Imaging: A Report of the ACC Competency Management Committee.
    J Am Coll Cardiol. 2025 Nov 18:S0735-1097(25)07261.
    >> Share

  49. OSTROMINSKI JW, Neuen BL, Claggett BL, Filippatos G, et al
    Timing of Cardiovascular and Kidney Benefits With Finerenone in Heart Failure and Chronic Kidney Disease With Type 2 Diabetes.
    J Am Coll Cardiol. 2025 Nov 18:S0735-1097(25)10071.
    >> Share

  50. TAVARES CAM, Guimaraes PO, Franken M, Junior JM, et al
    Potent P2Y(12) Inhibitor Monotherapy vs DAPT After PCI in Patients With and Without STEMI: The NEO-MINDSET Substudy.
    J Am Coll Cardiol. 2025 Nov 18:S0735-1097(25)10069.
    >> Share

  51. HEIDENREICH PA
    Giga-Trials Support Vaccination as Secondary Prevention for Cardiovascular Disease.
    J Am Coll Cardiol. 2025 Nov 14:S0735-1097(25)09944.
    >> Share

  52. ACQUAH I, Hagan K, Shapiro M, Rikhi RR, et al
    Interplay of Coronary Artery Calcium and PREVENT Equations in Atherosclerotic Cardiovascular Disease Risk Prediction.
    J Am Coll Cardiol. 2025 Nov 12:S0735-1097(25)09464.
    >> Share

  53. LI Z, Doudesis D, Bularga A, Wereski R, et al
    Safety of Using Risk Stratification Along With High-Sensitivity Cardiac Troponin in the Emergency Department: A Secondary Analysis.
    J Am Coll Cardiol. 2025;86:1738-1748.
    >> Share

  54. BHATIA HS, McParland J, Rikhi R, Tsai M, et al
    Association of Lipoprotein(a) and Interleukin-6 With Cardiovascular Risk: MESA and UK Biobank.
    J Am Coll Cardiol. 2025 Nov 10:S0735-1097(25)09481.
    >> Share

  55. MARTI-CASTELLOTE PM, Badrouchi S, Claggett B, Xu D, et al
    Using Artificial Intelligence to Adjudicate Major Adverse Cardiovascular Events in Clinical Trials.
    J Am Coll Cardiol. 2025 Nov 9:S0735-1097(25)10066.
    >> Share

  56. KRAMER CM, Lewis SJ, Wood MJ
    Transforming Cardiovascular Leadership Through Strategic Investment.
    J Am Coll Cardiol. 2025 Nov 5:S0735-1097(25)09821.
    >> Share

  57. YANG E, Ferdinand KC
    Ushering in a New Approach for Primary Prevention: Guidelines for Assessing Cardiovascular Risk.
    J Am Coll Cardiol. 2025;86:1532-1535.
    >> Share

  58. WU Y, Neal B, Miranda JJ, Labarthe D, et al
    Salt Substitution for Hypertension and Cardiovascular Disease Prevention: The SSaSS Trial and Beyond.
    J Am Coll Cardiol. 2025;86:1504-1506.
    >> Share

    October 2025
  59. YIN Y, Wang X, Zheng K, Sun T, et al
    Safety and Efficacy of Intensive BP Control in Cardiovascular-Kidney-Metabolic Syndrome: A Post Hoc Analysis of the SPRINT Trial.
    J Am Coll Cardiol. 2025;86:1452-1455.
    >> Share

  60. MCCARTHY CP, McEvoy JW, Brown JM
    PREVENTing Hypertensive Cardiovascular Disease: Where to Draw the Line?
    J Am Coll Cardiol. 2025;86:1449-1451.
    >> Share

  61. DE WINTER RW, Hoek R, Walsh SJ, Hanratty CG, et al
    PCI of Native Coronary Artery vs Saphenous Vein Graft After Prior Bypass Surgery: A Multicenter, Randomized Trial.
    J Am Coll Cardiol. 2025 Oct 28:S0735-1097(25)09477.
    >> Share

  62. AHMAD Y, Reddy RK, Yeh RW
    Beyond technical feasibility in complex percutaneous coronary intervention: lessons on equipoise, evidence and dogma from the PROCTOR Trial.
    J Am Coll Cardiol. 2025 Oct 28:S0735-1097(25)09923.
    >> Share

  63. MEHTA SR, Pinilla-Echeverri N, Tiong D, Kovalova T, et al
    Intracoronary Low-Dose Recombinant Tissue Plasminogen Activator in Primary PCI for ST-Segment Elevation Myocardial Infarction and Large Thrombus Burden: A Randomized Trial.
    J Am Coll Cardiol. 2025 Oct 25:S0735-1097(25)09815.
    >> Share

  64. TIAN Y, Cao X, Wang X, Zheng C, et al
    LDL-C-Related Cardiovascular Burden in China 2010 to 2030: Spatiotemporal Patterns and Scenario-Based Projections.
    J Am Coll Cardiol. 2025 Oct 15:S0735-1097(25)09513.
    >> Share

  65. FEZZI S, Serruys PW, Cortese B, Scheller B, et al
    Indications for Use of Drug-Coated Balloons in Coronary Intervention: Academic Research Consortium Position Statement.
    J Am Coll Cardiol. 2025;86:1170-1202.
    >> Share

  66. IMBESI A, Greco A, Spagnolo M, Laudani C, et al
    Targeting Inflammation After Acute Myocardial Infarction.
    J Am Coll Cardiol. 2025;86:1146-1169.
    >> Share

  67. KHETARPAL SA, Shi Z, Goyal A, Patel AP, et al
    Combining Polygenic Risk With LDL, CRP, and Lp(a) to Predict Coronary Artery Disease: UK Biobank Study.
    J Am Coll Cardiol. 2025 Oct 14:S0735-1097(25)07625.
    >> Share

  68. LOPEZ-AYALA P, Boeddinghaus J, Koechlin L, Bima P, et al
    Incremental Value of Cardiac Myosin-Binding Protein C for the Early Diagnosis of Acute Myocardial Infarction.
    J Am Coll Cardiol. 2025 Oct 13:S0735-1097(25)07767.
    >> Share

  69. AMPONSAH DK, Elliott A, Harris E, Ramratnam M, et al
    The Underestimated Cardiovascular Research Participant: The U.S. Veteran.
    J Am Coll Cardiol. 2025 Oct 11:S0735-1097(25)07692.
    >> Share

  70. ZHENG C, Wang X, Gu R, Wang W, et al
    The Burden of Cardiovascular Disease in China: Incidence Estimates From National Surveillance (2023).
    J Am Coll Cardiol. 2025 Oct 8:S0735-1097(25)07615.
    >> Share

  71. LEE H, Huang X, Khan SS, Son D, et al
    Very High Prevalence of Nonoptimally Controlled Traditional Risk Factors at the Onset of Cardiovascular Disease.
    J Am Coll Cardiol. 2025;86:1017-1029.
    >> Share

    September 2025
  72. BERMAN AN, Mukhopadhyay A, Blecker SB, Horwitz LI, et al
    Reimagining Cardiovascular Screening: Leveraging Detection for Population Health Impact.
    J Am Coll Cardiol. 2025;86:959-961.
    >> Share

  73. MENSAH GA, Arnold N, Prabhu SD, Ridker PM, et al
    Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology.
    J Am Coll Cardiol. 2025 Sep 29:S0735-1097(25)07555.
    >> Share

  74. MASRI A, Judge DP, Ruberg FL, Gillmore JD, et al
    Effect of Acoramidis on Recurrent and Cumulative Cardiovascular Outcomes in ATTR-CM: Exploratory Analysis From ATTRibute-CM.
    J Am Coll Cardiol. 2025 Sep 28:S0735-1097(25)07774.
    >> Share


  75. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023.
    J Am Coll Cardiol. 2025 Sep 24:S0735-1097(25)07428.
    >> Share

  76. REYNOLDS HR
    Incidence and Causes of Myocardial Infarction in Younger Women and Men.
    J Am Coll Cardiol. 2025;86:889-891.
    >> Share

  77. ZHAO B, Zhang J, Xie Y, Wu Z, et al
    Intensive vs Conventional Intraoperative Blood Pressure Management on Cardiovascular Events After Major Abdominal Surgery: The BP-CARES Randomized Trial.
    J Am Coll Cardiol. 2025;86:892-906.
    >> Share

  78. KRUMHOLZ HM
    Guiding the AI Revolution in Cardiovascular Medicine.
    J Am Coll Cardiol. 2025;86:843-845.
    >> Share

  79. IKEMURA N, Jones PG, Fu Z, Chan PS, et al
    Trajectories of Angina After Initial Invasive vs Conservative Strategy for Chronic Coronary Disease.
    J Am Coll Cardiol. 2025;86:782-793.
    >> Share

  80. SAURA O, Hekimian G, Del Marmol G, Lucenteforte M, et al
    Effect of ECMO Flow Variations on Pulmonary Capillary Wedge Pressure in Patients With Cardiogenic Shock.
    J Am Coll Cardiol. 2025;86:768-778.
    >> Share

  81. JAIN SS, Mortazavi BJ, Chan You S, Yao X, et al
    Moving Beyond the Model: Our Perspective on Meaningful AI Research in Cardiovascular Care.
    J Am Coll Cardiol. 2025;86:691-695.
    >> Share

  82. PENG AW, Razavi AC, Wilkins JT, Allen NB, et al
    Impact of LDL-Cholesterol When the Coronary Artery Calcium Score Is 0: Long-Term Cardiovascular Events.
    J Am Coll Cardiol. 2025;86:676-680.
    >> Share

    August 2025
  83. YANG S, Hu X, Zhang J, Jiang J, et al
    Long-Term Outcomes After Fractional Flow Reserve vs Intravascular Ultrasound to Guide PCI: The FLAVOUR Trial Extended Follow-Up.
    J Am Coll Cardiol. 2025;86:593-606.
    >> Share

  84. ARUN AS, Sawano M, Lu Y, Warner F, et al
    Update to the JACC Report Card: Excess Cardiovascular Mortality Among Black Americans, 2000-2023.
    J Am Coll Cardiol. 2025;86:559-562.
    >> Share

  85. KHAN SS, Lloyd-Jones DM, Abdalla M, Bello NA, et al
    Use of Risk Assessment to Guide Decision-Making for Blood Pressure Management in the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
    J Am Coll Cardiol. 2025 Aug 26:S0735-1097(25)07342.
    >> Share

  86. D'ASCENZO F, Cerrato E, De Filippo O, Gaido L, et al
    Computed Tomography Angiography or Standard Care After Left Main PCI?
    J Am Coll Cardiol. 2025 Aug 26:S0735-1097(25)07401.
    >> Share

  87. PICCOLO R, Calabro P, Carrara G, Simonetti F, et al
    Personalized or Standard Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: PARTHENOPE Randomized Trial.
    J Am Coll Cardiol. 2025 Aug 25:S0735-1097(25)07548.
    >> Share

  88. EZZAT D, Uddin MM, Xue L, Pershad Y, et al
    Clonal Hematopoiesis and Cardiovascular Outcomes in Older Women.
    J Am Coll Cardiol. 2025 Aug 22:S0735-1097(25)07388.
    >> Share

  89. A HEIDENREICH P, Bhatt A, Nazir NT, Schaffner W, et al
    2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on Adult Immunizations as Part of Cardiovascular Care: A Report of the American College of Cardiology Solution Set Oversight Committee.
    J Am Coll Cardiol. 2025 Aug 21:S0735-1097(25)07089.
    >> Share

  90. RAY KK, Szarek M, Bhatt DL, Bittner VA, et al
    Lipoprotein(a) identifies patients with acute coronary syndromes who derive cardiovascular benefit from alirocumab, particularly for limb events.
    J Am Coll Cardiol. 2025 Aug 21:S0735-1097(25)07551.
    >> Share

  91. KRUMHOLZ HM, Pagidipati NJ
    Obicetrapib and Cardiovascular Events: A Promising Signal in Need of Confirmation.
    J Am Coll Cardiol. 2025 Aug 21:S0735-1097(25)07430.
    >> Share

  92. GALLONE G, Baldetti L, Veen KM, Bernhardt AM, et al
    Trade-Off Between Bleeding and Ischemic Events From Left Ventricular Assist Devices: A EUROMACS Registry Analysis.
    J Am Coll Cardiol. 2025 Aug 21:S0735-1097(25)07381.
    >> Share

  93. OSTROMINSKI JW, Harrington J, Claggett BL, Filippatos G, et al
    Anthropometric Measures, Cardiovascular Outcomes, and Treatment Effects of Finerenone in Cardiovascular-Kidney-Metabolic Disease: Pooled Participant-Level Analysis of Three Global Trials.
    J Am Coll Cardiol. 2025 Aug 20:S0735-1097(25)07505.
    >> Share

  94. NICHOLLS SJ, Nelson AJ, Ray KK, Ballantyne CM, et al
    Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients: A Pooled Analysis.
    J Am Coll Cardiol. 2025 Aug 20:S0735-1097(25)07383.
    >> Share

  95. BABER U
    Bleeding and Thrombotic Risk After Percutaneous Coronary Intervention: No Longer a Zero-Sum Game.
    J Am Coll Cardiol. 2025;86:499-501.
    >> Share

  96. KADAKIA KT, Dhruva SS, Krumholz HM
    The Role of Clinicians in Advancing Cardiovascular Device Safety.
    J Am Coll Cardiol. 2025;86:481-484.
    >> Share

  97. KIRTANE AJ, Shlofmitz R, Moses J, Bachinsky W, et al
    Paclitaxel-Coated Balloon for the Treatment of Multilayer In-Stent Restenosis: AGENT IDE Subgroup Analysis.
    J Am Coll Cardiol. 2025;86:502-511.
    >> Share

  98. HALLER PM, Melloni GEM, Berg DD, Kamanu FK, et al
    A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular Risk.
    J Am Coll Cardiol. 2025 Aug 19:S0735-1097(25)07028.
    >> Share

  99. INOUE S
    Reassessing Clonal Hematopoiesis as a Cardiovascular Risk Factor in Older Women: It's Not Just Age.
    J Am Coll Cardiol. 2025 Aug 19:S0735-1097(25)07497.
    >> Share

  100. GALLI M, Benenati S, Laudani C, Simeone B, et al
    Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,592 patients.
    J Am Coll Cardiol. 2025 Aug 19:S0735-1097(25)07492.
    >> Share

  101. RAPHAEL CE, Sandoval Y, Beachey JD, Roger V, et al
    Causes of Myocardial Infarction in Younger Patients: Troponin-Elevation in Persons
    J Am Coll Cardiol. 2025 Aug 7:S0735-1097(25)07120.
    >> Share

  102. KRAMER CM
    Leading With Purpose: ACC's Global Commitment to Cardiovascular Health.
    J Am Coll Cardiol. 2025 Aug 4:S0735-1097(25)07100.
    >> Share

  103. TAN S, Nelson AJ, Muthalaly RG, Nerlekar N, et al
    Pop-Up Cardiovascular Screening Within Community Pharmacies and an International Sporting Event.
    J Am Coll Cardiol. 2025 Aug 4:S0735-1097(25)07177.
    >> Share

    July 2025
  104. MARTINEZ A, Etiwy M, Januzzi JL Jr, McCarthy CP, et al
    Misclassification of Myocardial Infarction Subtypes in Administrative Claims: Implications for Clinical Epidemiology and Quality Assessment.
    J Am Coll Cardiol. 2025;86:284-286.
    >> Share

  105. HAERTEL F, Schulze PC, Davis HR, Weingartner O, et al
    Reducing Cardiovascular Events With Early Ezetimibe: Getting to "Europe on Target" From "Jena auf Ziel".
    J Am Coll Cardiol. 2025;86:e25-e26.
    >> Share

  106. HUANG X, Zhang H, Li Y, Ge J, et al
    Modest Effects of Intensive Blood Pressure-Lowering on Quality of Life in Patients at High Cardiovascular Risk: The ESPRIT trial.
    J Am Coll Cardiol. 2025 Jul 25:S0735-1097(25)06777.
    >> Share

  107. NEWMAN JD, Rajagopalan S, Brook RD
    Breathing Easier: Air Filtration to Improve Indoor Air Quality as a Cardiovascular Intervention.
    J Am Coll Cardiol. 2025 Jul 23:S0735-1097(25)06968.
    >> Share

  108. OSTROMINSKI JW, Hirsch JS, Miao B, Clark B, et al
    Risk Factor Control in U.S. Adults With Cardiovascular-Kidney-Metabolic Multimorbidity, 1999-2020.
    J Am Coll Cardiol. 2025;86:217-221.
    >> Share

  109. HE D, Zhang X, Li C, Yang C, et al
    Rising Prevalence of Cardiovascular-Kidney-Metabolic Syndrome in China, 2010-2019: National Cross-Sectional Surveys.
    J Am Coll Cardiol. 2025;86:213-216.
    >> Share

  110. CHO SMJ, Levin M, Chen R, Samarakoon R, et al
    AHA PREVENT Equations and Cardiovascular Disease Risk in Diverse Health Care Populations.
    J Am Coll Cardiol. 2025;86:181-192.
    >> Share

  111. SCHWARTZ JI, Ssinabulya I, Kayima J, Longenecker CT, et al
    Syndemic Interactions and Cardiovascular Risk Factors: More Than Just a Sum of the Parts.
    J Am Coll Cardiol. 2025;86:178-180.
    >> Share

  112. CHONG B, Jayabaskaran J, Jauhari SM, Chia J, et al
    The Global Syndemic of Modifiable Cardiovascular Risk Factors Projected From 2025 to 2050.
    J Am Coll Cardiol. 2025;86:165-177.
    >> Share

  113. WATKINS DA, Pickersgill SJ, Flood D, Gaziano TA, et al
    Global Impact of Fixed-Dose Combination Therapies on Cardiovascular Mortality and Events, 2023-2050: A Modeling Study.
    J Am Coll Cardiol. 2025;86:149-161.
    >> Share

  114. COVANI M, Niccoli G, Fujimoto D, Scalamera R, et al
    Plaque Vulnerability and Cardiovascular Risk Factor Burden in Acute Coronary Syndrome: An Optical Coherence Tomography Analysis.
    J Am Coll Cardiol. 2025;86:77-89.
    >> Share

  115. JOHNSON TW, Bergmark BA, Croce K, Pellegrini D, et al
    Impact of Optical Coherence Tomography-Based Post-PCI Physiology Assessment to Predict Clinical Outcomes: An ILUMIEN-IV Substudy.
    J Am Coll Cardiol. 2025;86:93-102.
    >> Share

  116. EFTEKHARI A, Jensen LO, Veien K, Raungaard B, et al
    Biolimus-Eluting Biomatrix Stent vs a Dual-Therapy Sirolimus-Eluting Stent in PCI: The SORT OUT XI Randomized Trial.
    J Am Coll Cardiol. 2025;86:106-115.
    >> Share

  117. MARQUARD JM, Beske RP, Kelbaek H, Holmvang L, et al
    10-Year Outcome of Complete or Infarct Artery-Only Revascularization in STEMI With Multivessel Disease: The DANAMI-3-PRIMULTI Study.
    J Am Coll Cardiol. 2025;86:119-129.
    >> Share

  118. BEN-YEHUDA O
    From Epidemiology to Acute Coronary Syndromes: Risk Factors and Plaque Vulnerability.
    J Am Coll Cardiol. 2025;86:90-92.
    >> Share

  119. AL-LAMEE RK, Zaman S
    Introducing the Lancet Commission on Coronary Artery Disease.
    J Am Coll Cardiol. 2025;86:144-145.
    >> Share

  120. DANGAS K, Kadakia KT, Ferro EG, Song Y, et al
    Outpatient Migration of Cardiovascular Procedures in the United States.
    J Am Coll Cardiol. 2025;86:133-143.
    >> Share

  121. KEREIAKES DJ
    Contemporary Coronary Stents and Noninferiority Clinical Trials.
    J Am Coll Cardiol. 2025;86:116-118.
    >> Share

  122. MILLER PE, Brusca SB, Ko DT, Dhruva SS, et al
    The Potential Role of Early Left Ventricular Unloading in ST-Segment Elevation Myocardial Infarction-Related Cardiogenic Shock.
    J Am Coll Cardiol. 2025;85:2469-2471.
    >> Share

  123. MOLLER JE, Beske RP, Jensen LO, Eiskjaer H, et al
    Effect of Microaxial Flow Pump on Hemodynamics in STEMI-Related Cardiogenic Shock.
    J Am Coll Cardiol. 2025;85:2456-2468.
    >> Share

  124. YAN BW, Arun AS, Curtis LH, Kadakia KT, et al
    JACC Data Report: Cardiovascular Disease Mortality Trends in the United States (1999-2023).
    J Am Coll Cardiol. 2025;85:2495-2498.
    >> Share

  125. JAMIL Y, Krishnaswami A, Orkaby AR, Stimmel M, et al
    The Impact of Cognitive Impairment on Cardiovascular Disease.
    J Am Coll Cardiol. 2025;85:2472-2491.
    >> Share

    June 2025
  126. JANSSEN SLJE, van Everdingen WM, Saalmink WBJ, Lamers SK, et al
    Relationship Between Exercise-Induced Cardiac Troponin Elevations and Occult Coronary Atherosclerosis in Middle-Aged Athletes.
    J Am Coll Cardiol. 2025;85:2370-2382.
    >> Share

  127. MCCARTHY CP, Wasfy MM
    Exercise-Induced Troponin Elevation and Coronary Atherosclerosis: Have We Crossed the Finish Line?
    J Am Coll Cardiol. 2025;85:2383-2385.
    >> Share

  128. PATEL SM, Giugliano RP, Morrow DA, Parkar S, et al
    Long-Acting Factor XI Inhibition and Periprocedural Bleeding: An Analysis From AZALEA-TIMI 71.
    J Am Coll Cardiol. 2025;85:2288-2298.
    >> Share

  129. KHAN SS
    Navigating the Long Road Ahead in Cardiovascular Disease Prevention Using the PREVENT Equations.
    J Am Coll Cardiol. 2025;85:2250-2252.
    >> Share

  130. FARIDI KF, Malik D, Essa M, Yang H, et al
    10-Year and 30-Year Risks of Cardiovascular Disease in the U.S. Population.
    J Am Coll Cardiol. 2025;85:2239-2249.
    >> Share

  131. FREED BH, Afari ME, Abideen Asad ZUL, Banerjee D, et al
    Signaling 101 for Cardiovascular Disease Fellowship Recruitment.
    J Am Coll Cardiol. 2025 Jun 17:S0735-1097(25)06768.
    >> Share

  132. GILBERT O, Gulati M, Gluckman TJ, Kittleson MM, et al
    2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on Medical Weight Management for Optimization of Cardiovascular Health: A Report of the American College of Cardiology Solution Set Oversight Committee.
    J Am Coll Cardiol. 2025 Jun 16:S0735-1097(25)06504.
    >> Share

  133. KRAMER CM, Echols MR
    Health Equity in Cardiovascular Care: A Clinical Imperative for Better Outcomes.
    J Am Coll Cardiol. 2025 Jun 11:S0735-1097(25)06491.
    >> Share

  134. MURUGIAH K, McDonagh TA, Cohen DJ, Dhruva SS, et al
    Mechanical Circulatory Support in Acute Myocardial Infarction-Cardiogenic Shock: 2025 Acute Coronary Syndrome Guideline in Context.
    J Am Coll Cardiol. 2025;85:2103-2106.
    >> Share

  135. KAUL S
    Reevaluating Beta-Blocker Recommendations Post-Myocardial Infarction: Perspective on the 2025 Guideline Update.
    J Am Coll Cardiol. 2025;85:2096-2099.
    >> Share

  136. FURTADO RHM, Rochitte CE, Nicolau JC, Echeverria LE, et al
    American College of Cardiology/American Heart Association Acute Coronary Syndrome Guidelines: A Latin American Perspective.
    J Am Coll Cardiol. 2025;85:2122-2125.
    >> Share

  137. SAWANO M, Du X, Wong ND, You SC, et al
    The 2025 Guideline for the Management of Patients With Acute Coronary Syndromes: Asian Perspective.
    J Am Coll Cardiol. 2025;85:2114-2117.
    >> Share

  138. BELTRAME JF, Nicholls SJ
    The 2025 ACC/AHA Guideline for Acute Coronary Syndromes: A View From Down Under.
    J Am Coll Cardiol. 2025;85:2111-2113.
    >> Share

  139. BRANDTS J, Ray KK
    Maturation of Lipid Management in the 2025 ACC/AHA Acute Coronary Syndrome Guideline: What It Is and What It Might Have Been.
    J Am Coll Cardiol. 2025;85:2107-2110.
    >> Share

  140. RIDKER PM
    Colchicine for Cardiovascular Disease: Navigating the Gap Between Evidence, Guidelines, and Clinical Practice.
    J Am Coll Cardiol. 2025;85:2092-2095.
    >> Share

  141. KO DT, Al-Lamee RK, Bikdeli B, Cohen DJ, et al
    Perspective on the Choice and Duration of Dual Antiplatelet Therapy Recommendations in the 2025 Acute Coronary Syndrome Management Guideline.
    J Am Coll Cardiol. 2025;85:2079-2082.
    >> Share

  142. BIKDELI B, Ujueta F, Rashedi S, Talasaz AH, et al
    Antiplatelet and Anticoagulant Therapy in the 2025 ACC/AHA Guideline for Acute Coronary Syndromes: Key Recommendations.
    J Am Coll Cardiol. 2025;85:2074-2078.
    >> Share

  143. RAO SV
    The 2025 American College of Cardiology/American Heart Association Acute Coronary Syndrome Guideline: A Personal Perspective.
    J Am Coll Cardiol. 2025;85:2068-2070.
    >> Share

  144. ANTMAN EM, Braunwald E
    Acute Coronary Syndromes: A Holistic View.
    J Am Coll Cardiol. 2025;85:2057-2060.
    >> Share

  145. BUDDE RPJ, Faure ME, Abbara S, Alkadhi H, et al
    Cardiac Computed Tomography for Prosthetic Heart Valve Assessment: An Expert Consensus Document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the European Society of Cardiovascular Radiology (ES
    J Am Coll Cardiol. 2025 Jun 10:S0735-1097(25)06617.
    >> Share

  146. BARKAS F, Brandts J, De Bacquer D, Jennings C, et al
    Global Variation in Lipoprotein(a) Levels Among Patients With Coronary Heart Disease: Insights From the INTERASPIRE Study and Implications for Emerging Lp(a)-Lowering Therapies.
    J Am Coll Cardiol. 2025;85:2028-2042.
    >> Share

  147. ERLINGE D, Tsimikas S, Maeng M, Maehara A, et al
    Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques: A PROSPECT II Substudy.
    J Am Coll Cardiol. 2025;85:2011-2024.
    >> Share

    May 2025
  148. SCHWARTZ GG, Cobbaert CM
    Plozasiran and Apolipoprotein C-III Inhibition: Lipoprotein Particle Insights and Cardiovascular Implications.
    J Am Coll Cardiol. 2025;85:1855-1857.
    >> Share

  149. MARK DB, Nanna MG, Douglas PS
    Connecting Anatomic Coronary Disease and Functional Ischemia With Treatment of Patient-Reported Angina: A Jigsaw Puzzle of Surprising Complexity.
    J Am Coll Cardiol. 2025;85:1754-1756.
    >> Share

  150. AHMED-JUSHUF F, Foley MJ, Rajkumar CA, Chotai S, et al
    Ischemia on Dobutamine Stress Echocardiography Predicts Efficacy of PCI: Results From the ORBITA-2 Trial.
    J Am Coll Cardiol. 2025;85:1740-1753.
    >> Share

  151. IKEMURA N, Chan PS, Cohen DJ, Kennedy KF, et al
    Trends and Physician-Level Variation in Contrast Volume During Percutaneous Coronary Intervention: Insights From the NCDR CathPCI Registry.
    J Am Coll Cardiol. 2025;85:1792-1795.
    >> Share

  152. BONGIOVANNI D, Landi A, Frigoli E, Heg D, et al
    Recurrent Events Analysis of MASTER DAPT: Total Ischemic and Bleeding Events After Abbreviated vs Prolonged DAPT in HBR Patient.
    J Am Coll Cardiol. 2025 May 7:S0735-1097(25)06483.
    >> Share

    April 2025
  153. WITTELES RM, Garcia-Pavia P, Damy T, Grogan M, et al
    Vutrisiran Improves Survival and Reduces Cardiovascular Events in ATTR Amyloid Cardiomyopathy: HELIOS-B.
    J Am Coll Cardiol. 2025 Apr 30:S0735-1097(25)06170.
    >> Share

  154. CHOW CK, Archer O, Kritharides L
    Should Patients With Myocardial Infarction Be Started on Combination Therapy With Ezetimibe Before Hospital Discharge?
    J Am Coll Cardiol. 2025;85:1565-1567.
    >> Share

  155. LEOSDOTTIR M, Schubert J, Brandts J, Gustafsson S, et al
    Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry.
    J Am Coll Cardiol. 2025;85:1550-1564.
    >> Share

  156. KRUMHOLZ HM
    Black Lives and Cardiovascular Deaths.
    J Am Coll Cardiol. 2025;85:1576-1577.
    >> Share

  157. SHARMA G, Powell-Wiley TM, Brazile TL
    Maternal Obesity and Adverse Pregnancy Outcomes as Mediators of Cardiovascular Disease Risk in Midlife.
    J Am Coll Cardiol. 2025;85:1547-1549.
    >> Share

  158. BORROWMAN JD, Huang X, Petito LC, Perak AM, et al
    Prepregnancy Adiposity, Adverse Pregnancy Outcomes, and Cardiovascular Disease Risk in Midlife.
    J Am Coll Cardiol. 2025;85:1536-1546.
    >> Share

  159. WILLIAMS MS, Levine GN, Kalra D, Agarwala A, et al
    2025 AHA/ACC Clinical Performance and Quality Measures for Patients With Chronic Coronary Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures.
    J Am Coll Cardiol. 2025 Apr 22:S0735-1097(25)00282.
    >> Share

  160. MATHEW V, Khan RR, Jowell AR, Yan Q, et al
    Genetic Risk and First-Trimester Cardiovascular Health Predict Hypertensive Disorders of Pregnancy in Nulliparous Women.
    J Am Coll Cardiol. 2025;85:1488-1500.
    >> Share

  161. MCCARTHY CP, McEvoy JW, Januzzi JL Jr
    Troponin Testing for Cardiovascular Primary Prevention Decision Making?
    J Am Coll Cardiol. 2025;85:1485-1487.
    >> Share

  162. SHAH ASV, Keene SJ, Pennells L, Kaptoge S, et al
    Cardiac Troponins and Cardiovascular Disease Risk Prediction: An Individual-Participant-Data Meta-Analysis.
    J Am Coll Cardiol. 2025;85:1471-1484.
    >> Share

  163. BIGA C, Blackwell J, Bradley SM, Lakkireddy D, et al
    Translating Guidance Into Practice: The Final Common Pathway in Cardiovascular Care Delivery.
    J Am Coll Cardiol. 2025 Apr 15:S0735-1097(25)06007.
    >> Share

  164. KRAMER CM
    My Fantastic Voyage: Innovation, Mentorship, and the Future of Cardiovascular Medicine.
    J Am Coll Cardiol. 2025 Apr 15:S0735-1097(25)06119.
    >> Share

  165. SU Q, Zeng X
    The Role of Geriatric Expertise on Cardiovascular Outcomes When Cardiologists Are Employed by Hospitals.
    J Am Coll Cardiol. 2025 Apr 10:S0735-1097(25)05902.
    >> Share

  166. KADAKIA KT, Krumholz HM
    FDA's Proposed Nicotine Regulations: A New Frontier for Cardiovascular Health.
    J Am Coll Cardiol. 2025;85:1459-1461.
    >> Share

  167. DEAN PN, Brothers JA, Burns K, Edelson JB, et al
    The Cardiovascular Care of the Pediatric Athlete.
    J Am Coll Cardiol. 2025;85:1434-1454.
    >> Share

  168. BANGALORE S, Mancini GBJ, Leipsic J, Budoff MJ, et al
    Invasive vs Conservative Management of Patients With Chronic Total Occlusion: Results From the ISCHEMIA Trial.
    J Am Coll Cardiol. 2025;85:1335-1349.
    >> Share

  169. MARON DJ, Newman JD, Anthopolos R, Lu Y, et al
    Guideline-Directed Medical Therapy and Outcomes in the ISCHEMIA Trial.
    J Am Coll Cardiol. 2025;85:1317-1331.
    >> Share

  170. VAUGHAN LE, Garovic VD
    Reply: Social Work Interventions to Reduce Cardiovascular Risk in Women With Hypertensive Disorders of Pregnancy.
    J Am Coll Cardiol. 2025;85:e131.
    >> Share

  171. ZHOU R, Ye S, Liu J, Duan L, et al
    Social Work Interventions to Reduce Cardiovascular Risk in Women With Hypertensive Disorders of Pregnancy.
    J Am Coll Cardiol. 2025;85:e129-e130.
    >> Share

    March 2025
  172. SHURRAB M, Ko DT
    Fewer Drugs, Less Bleeding in Atrial Fibrillation With Stable Coronary Artery Disease: Less Is More.
    J Am Coll Cardiol. 2025;85:1204-1206.
    >> Share

  173. KUVIN JT, Sibley J, Kramer CM, Biga C, et al
    The Winding Road to an Independent Cardiovascular Board: Where Do We Go From Here?
    J Am Coll Cardiol. 2025 Mar 24:S0735-1097(25)05897.
    >> Share

  174. BAIREY MERZ CN, Bonow RO, Carnethon M, Crea F, et al
    The Role of Cardiovascular Disease Journals in Reporting Sex and Gender in Research.
    J Am Coll Cardiol. 2025 Mar 24:S0735-1097(25)05281.
    >> Share

  175. BLOM DJ, Gaudet D
    Beyond LDL: Targeting ANGPTL3 to Reduce Residual Cardiovascular Risk.
    J Am Coll Cardiol. 2025 Mar 24:S0735-1097(25)05927.
    >> Share

  176. MORICI N, Sacco A, Frea S, Rota M, et al
    Early Intra-Aortic Balloon Support for Heart Failure-Related Cardiogenic Shock: A Randomized Clinical Trial.
    J Am Coll Cardiol. 2025 Mar 21:S0735-1097(25)05334.
    >> Share

  177. THOMAS PE, Vedel-Krogh S, Kamstrup PR, Nordestgaard BG, et al
    Lipoprotein(a) Cardiovascular Risk Explained by LDL Cholesterol, Non-HDL Cholesterol, ApoB, or hsCRP Is Minimal.
    J Am Coll Cardiol. 2025 Mar 19:S0735-1097(25)00484.
    >> Share

  178. MCGRAW KE, Shea S, Navas-Acien A, Sanchez TR, et al
    Reply: Urinary Metal Levels and Coronary Artery Calcification: Potential Confounders.
    J Am Coll Cardiol. 2025;85:e111.
    >> Share

  179. WU J, Zhang Z, Zhang L
    Environmental Metal Exposure and Cardiovascular Disease Risk.
    J Am Coll Cardiol. 2025;85:e109.
    >> Share

  180. CHAZAL RA, Lopez-Mattei J, Gaztanaga J
    Urinary Metal Levels and Coronary Artery Calcification: Potential Confounders.
    J Am Coll Cardiol. 2025;85:e107.
    >> Share

  181. GRONDIN S, Neveu B, Soltani I, Alaoui AA, et al
    Clinical Effect of Genetic Testing in Inherited Cardiovascular Diseases: A 14-Year Retrospective Study.
    J Am Coll Cardiol. 2025;85:988-999.
    >> Share

  182. TANG GHL
    The Value of Case-Based Learning in Cardiovascular Medicine.
    J Am Coll Cardiol. 2025;85:1058.
    >> Share

  183. GALVIN O, Nasir K, McEvoy JW
    The Cardiovascular Epidemiology of Smoking: Past, Present, and Future.
    J Am Coll Cardiol. 2025;85:1035-1037.
    >> Share

  184. YAO Z, Tasdighi E, Dardari ZA, Jha KK, et al
    Association Between Cigarette Smoking and Subclinical Markers of Cardiovascular Harm.
    J Am Coll Cardiol. 2025;85:1018-1034.
    >> Share

  185. JUDGE DP, Alexander KM, Cappelli F, Fontana M, et al
    Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy.
    J Am Coll Cardiol. 2025;85:1003-1014.
    >> Share

  186. LAWS JL, Davogustto GE, Wells QS
    Genetic Testing for Cardiovascular Disease: Evidence Grows But Challenges Remain.
    J Am Coll Cardiol. 2025;85:1000-1002.
    >> Share

  187. CHU L, Chen K
    Understanding the Cardiovascular Impacts of Heatwaves: Moving Beyond Simple Definitions.
    J Am Coll Cardiol. 2025 Mar 17:S0735-1097(25)00365.
    >> Share

  188. ESSA M, Decker SRR, Liang L, Song Y, et al
    Use of Cardiac Rehabilitation in Older Patients with Myocardial Infarction Complicated by Cardiogenic Shock.
    J Am Coll Cardiol. 2025 Mar 12:S0735-1097(25)05893.
    >> Share

  189. CANTEY EP, Lopacinski A, Seth M, Hamilton DE, et al
    Managing Cardiogenic Shock Caused by Acute Myocardial Infarction: Invisible Challenges Revealed in a Statewide Registry.
    J Am Coll Cardiol. 2025 Mar 10:S0735-1097(25)05209.
    >> Share

  190. LASSEN MCH, Modin D, Johansen ND, Sivapalan P, et al
    Respiratory Syncytial Virus and Incidence of Cardiovascular Events: A Nationwide Self-Controlled Case Series Analysis.
    J Am Coll Cardiol. 2025 Mar 10:S0735-1097(25)05260.
    >> Share

  191. BHATT AB, Biesbrock GK, Biga C
    Best Practices for Transforming Cardiovascular Care Delivery and Implementation: A Modern Framework.
    J Am Coll Cardiol. 2025 Mar 10:S0735-1097(25)00468.
    >> Share

  192. VARTIAINEN PJ, Huang Y, Sawano M
    More Than an Infant's Respiratory Illness: The Unfolding Cardiovascular Consequences of RSV in Older Adults.
    J Am Coll Cardiol. 2025 Mar 6:S0735-1097(25)05338.
    >> Share

  193. KRUMHOLZ HM, Mori M, Geirsson A
    The Essential Role of Cardiovascular Surgery in Cardiology: A Perspective From JACC.
    J Am Coll Cardiol. 2025;85:785-787.
    >> Share

    February 2025
  194. RAO SV, O'Donoghue ML, Ruel M, Rab T, et al
    2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    J Am Coll Cardiol. 2025 Feb 27:S0735-1097(24)10424.
    >> Share

  195. KUMBHANI DJ, Cibotti-Sun M, Moore MM
    2025 Acute Coronary Syndromes Guideline-at-a-Glance.
    J Am Coll Cardiol. 2025 Feb 27:S0735-1097(25)00202.
    >> Share

  196. YANG H, Huang C, Sawano M, Herrin J, et al
    Systolic Blood Pressure and Cardiovascular Mortality in U.S. Adults Aged 80+ Taking Antihypertensive Medications.
    J Am Coll Cardiol. 2025 Feb 26:S0735-1097(25)00335.
    >> Share

  197. HESPE S, Waddell A, Asatryan B, Owens E, et al
    Genes Associated With Hypertrophic Cardiomyopathy: A Reappraisal by the ClinGen Hereditary Cardiovascular Disease Gene Curation Expert Panel.
    J Am Coll Cardiol. 2025;85:727-740.
    >> Share

  198. KIM JH, Baggish AL, Levine BD, Ackerman MJ, et al
    Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology.
    J Am Coll Cardiol. 2025 Feb 20:S0735-1097(24)10722.
    >> Share

  199. BIGA C, Narula J
    Strengthening Global Partnerships to Combat Cardiovascular Disease: A Call to Action.
    J Am Coll Cardiol. 2025 Feb 19:S0735-1097(25)00203.
    >> Share

  200. NG P, Maehara A, Kirtane AJ, McEntegart M, et al
    Management of Coronary Stent Underexpansion.
    J Am Coll Cardiol. 2025;85:625-644.
    >> Share

  201. KLEIN A, Beske RP, Hassager C, Jensen LO, et al
    Treating Older Patients in Cardiogenic Shock With a Microaxial Flow Pump: Is it DANGERous?
    J Am Coll Cardiol. 2025;85:595-603.
    >> Share

  202. YEH RW, Bertrand OF, Mahmud E, Barbato E, et al
    Randomized Comparison of Novel Low-Dose Sirolimus-Eluting Biodegradable Polymer Stent vs Second-Generation DES: TARGET-IV NA Trial.
    J Am Coll Cardiol. 2025;85:563-574.
    >> Share

  203. KRUMHOLZ HM, Wallach JD
    Preprints: A Revolution in Cardiovascular Science.
    J Am Coll Cardiol. 2025;85:652-654.
    >> Share

  204. ONG C, Caceres BA
    Altering Adverse Social Determinants of Cardiovascular Health in Sexual Minorities.
    J Am Coll Cardiol. 2025;85:526-527.
    >> Share

  205. SATTI DI, Chan JSK, Mszar R, Mehta A, et al
    Social Determinants of Health, Cardiovascular Health, and Mortality in Sexual Minority Individuals in the United States.
    J Am Coll Cardiol. 2025;85:515-525.
    >> Share

  206. MYHRE PL, Vaduganathan M
    Does the Mechanism of Weight Loss Matter for Cardiovascular Protection?
    J Am Coll Cardiol. 2025;85:501-503.
    >> Share

  207. ONUMA OK
    Making Secondary Prevention the Primary Focus for Cardiovascular Disease Control.
    J Am Coll Cardiol. 2025;85:451-453.
    >> Share

  208. CHATURVEDI A, Prabhakaran D
    PURE Evidence in Plain Sight: The Highs, Lows, and Gaps in Secondary Cardiovascular Prevention.
    J Am Coll Cardiol. 2025;85:448-450.
    >> Share

  209. MOGHTADERI A, Magid DJ, Yuan AY, Black B, et al
    The Association of Hospital-Cardiologist Integration With Patient Outcomes, Care Quality, and Utilization.
    J Am Coll Cardiol. 2025;85:352-361.
    >> Share

  210. ZAHGER D, Schwartz GG, Szarek M, Fazio S, et al
    Reply: Plasma Triglyceride Reduction and Cardiovascular Risk in ODYSSEY Outcomes Trial: Interpret With Caution.
    J Am Coll Cardiol. 2025;85:e55.
    >> Share

  211. PACKARD CJ, Boren J, John Chapman M
    Plasma Triglyceride Reduction and Cardiovascular Risk in ODYSSEY Outcomes Trial: Interpret With Caution.
    J Am Coll Cardiol. 2025;85:e53-e54.
    >> Share

    January 2025
  212. KRUMHOLZ HM
    Tricuspid Valve Interventions: A New Era in Cardiovascular Innovation.
    J Am Coll Cardiol. 2025;85:203-205.
    >> Share

  213. BUCHOLZ EM, Costello JM
    Redefining Outcomes in Pediatric Cardiovascular Research: The Promise of Days Alive Out of Health Care.
    J Am Coll Cardiol. 2025 Jan 24:S0735-1097(25)00019.
    >> Share

  214. TANNU M, Lopes RD, Wojdyla DM, Goodman SG, et al
    Antithrombotic Therapy to Minimize Total Events After ACS or PCI in Atrial Fibrillation: Insights From AUGUSTUS.
    J Am Coll Cardiol. 2025 Jan 24:S0735-1097(24)10555.
    >> Share

  215. CHEN K, Lu Y, Krumholz HM
    Wildfires, Compound Extreme Events, Climate Change, and Cardiovascular Health.
    J Am Coll Cardiol. 2025 Jan 21:S0735-1097(25)00136.
    >> Share

  216. SCHNEIDER A, Chen K, Breitner S
    The Pathogenetic Link Between Ozone Pollution and Cardiovascular Disease.
    J Am Coll Cardiol. 2025 Jan 17:S0735-1097(24)10658.
    >> Share

  217. RASHEDI S, Keykhaei M, Sato A, Steg PG, et al
    Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: Meta-Analysis of Randomized Trials.
    J Am Coll Cardiol. 2025 Jan 17:S0735-1097(25)00071.
    >> Share

  218. BEN-YEHUDA O, Mahmud E
    Complete Revascularization Wins in ST-Segment Elevation Myocardial Infarction, But Timing Remains Flexible.
    J Am Coll Cardiol. 2025;85:39-41.
    >> Share

  219. UEYAMA HA, Akita K, Kiyohara Y, Takagi H, et al
    Optimal Strategy for Complete Revascularization in ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A Network Meta-Analysis.
    J Am Coll Cardiol. 2025;85:19-38.
    >> Share

  220. GAO X, Tian N, Kan J, Li P, et al
    Drug-Coated Balloon Angioplasty of the Side Branch During Provisional Stenting: The Multicenter Randomized DCB-BIF Trial.
    J Am Coll Cardiol. 2025;85:1-15.
    >> Share

    December 2024
  221. MUNZEL T, Kuntic M, Stamm P, Schmidt F, et al
    The High Stakes of High Decibels: The Cardiovascular Fallout From Aircraft Noise.
    J Am Coll Cardiol. 2024 Dec 18:S0735-1097(24)10058.
    >> Share

  222. VAN ROYEN FS, Venekamp RP, Bruijning-Verhagen PCJL, Rutten FH, et al
    Acute Respiratory Infections Fuel Cardiovascular Disease.
    J Am Coll Cardiol. 2024;84:2468-2470.
    >> Share

  223. TOPRICEANU CC, Gong X, Shah M, Shiwani H, et al
    Higher Aircraft Noise Exposure Is Linked to Worse Heart Structure and Function by Cardiovascular MRI.
    J Am Coll Cardiol. 2024 Dec 13:S0735-1097(24)09797.
    >> Share

  224. THORN SL, Spinale FG, Sinusas AJ
    Imaging Fibroblast Activation Protein: Direct Visualization of Matrix Proteolytic Activity in Patients Post Myocardial Infarction.
    J Am Coll Cardiol. 2024 Dec 12:S0735-1097(24)10524.
    >> Share

  225. GIUSTINO G, Sabik JF 3rd, Serruys PW, Puskas JD, et al
    Major Bleeding and Mortality After Revascularization of Left Main Disease.
    J Am Coll Cardiol. 2024;84:2335-2346.
    >> Share

  226. WARRAICH HJ, Krumholz HM, Califf RM
    Giving Cardiovascular Clinicians a Voice in Evidence Generation: A Collaboration Between FDA and JACC.
    J Am Coll Cardiol. 2024 Dec 10:S0735-1097(24)10509.
    >> Share

  227. GYLDENKERNE C, Kahlert J, Thrane PG, Olesen KKW, et al
    2-Fold More Cardiovascular Disease Events Decades Before Type 2 Diabetes Diagnosis: A Nationwide Registry Study.
    J Am Coll Cardiol. 2024;84:2251-2259.
    >> Share

    November 2024
  228. BIGA C, Al Mahmeed W
    The Importance of Growing the Next Generation of Global Cardiovascular Leaders.
    J Am Coll Cardiol. 2024 Nov 27:S0735-1097(24)10425.
    >> Share

  229. NORLAND K, Schaid DJ, Naderian M, Na J, et al
    Associations of Self-Reported Race, Social Determinants of Health, and Polygenic Risk With Coronary Heart Disease.
    J Am Coll Cardiol. 2024;84:2157-2166.
    >> Share

  230. SANTOS-PARDO I, Andersson Franko M, Nystrom T
    Reply: Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus.
    J Am Coll Cardiol. 2024;84:e321.
    >> Share

  231. LIU C, Li X, Cong H
    Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus.
    J Am Coll Cardiol. 2024;84:e319-e320.
    >> Share

  232. SHAH NS
    Considering Social and Genetic Factors in Cardiovascular Disease Risk.
    J Am Coll Cardiol. 2024;84:2167-2169.
    >> Share

  233. BARTON AK, Craig NJ, Loganath K, Joshi S, et al
    Myocardial Fibroblast Activation After Acute Myocardial Infarction: A Positron Emission Tomography and Magnetic Resonance Study.
    J Am Coll Cardiol. 2024 Nov 26:S0735-1097(24)10315.
    >> Share

  234. BIGA C, Rose GA
    Navigating Cardiovascular Employment Trends.
    J Am Coll Cardiol. 2024;84:2150-2153.
    >> Share

  235. KIM JM, Yeh RW, Secemsky EA
    What Is the Rush?: Optimizing the Timing of P2Y(12) Inhibition in Non-ST-Segment Elevation Acute Coronary Syndromes.
    J Am Coll Cardiol. 2024 Nov 13:S0735-1097(24)10300.
    >> Share

  236. SANDNER S, Gaudino M
    Reply: Understanding Disparities in Coronary Artery Bypass Surgery Outcomes.
    J Am Coll Cardiol. 2024;84:e297.
    >> Share

  237. HOU R, Ren J
    Gender Disparities in Cardiovascular Literature: Expanding the Scope and Solutions.
    J Am Coll Cardiol. 2024;84:e279.
    >> Share

  238. CUNNINGHAM JW, Abraham WT, Bhatt AS, Dunn J, et al
    Artificial Intelligence in Cardiovascular Clinical Trials.
    J Am Coll Cardiol. 2024;84:2051-2062.
    >> Share

  239. AJUFO E, Kany S, Ramo JT, Churchill TW, et al
    Accelerometer-Measured Sedentary Behavior and Risk of Future Cardiovascular Disease.
    J Am Coll Cardiol. 2024 Nov 11:S0735-1097(24)09920.
    >> Share

  240. BLUMENTHAL DM, Hsu J
    Understanding The Impact of Vertical Integration on Cardiovascular Care Quality: A Complex and Worthwhile Endeavor.
    J Am Coll Cardiol. 2024 Nov 8:S0735-1097(24)10428.
    >> Share

  241. EATON CB
    Sedentary Behavior and Risk of Cardiovascular Disease.
    J Am Coll Cardiol. 2024 Nov 8:S0735-1097(24)10415.
    >> Share

  242. UEYAMA HA, Kennedy KF, Rymer JA, Sandhu AT, et al
    P2Y(12) Inhibitor Pretreatment in Non-ST-Segment Elevation Acute Coronary Syndrome: The NCDR Chest Pain-MI Registry.
    J Am Coll Cardiol. 2024 Nov 7:S0735-1097(24)09843.
    >> Share

  243. VERMA S, Emerson S, Plutzky J, Kahn SE, et al
    Semaglutide Improves Cardiovascular Outcomes in Patients With History of Coronary Artery Bypass Graft and Obesity.
    J Am Coll Cardiol. 2024 Nov 6:S0735-1097(24)10422.
    >> Share

  244. PATEL KV, Chunawala Z, Verma S, Segar MW, et al
    Intensive lifestyle intervention, cardiac biomarkers, and cardiovascular outcomes in diabetes: LookAHEAD cardiac biomarker ancillary study.
    J Am Coll Cardiol. 2024 Nov 5:S0735-1097(24)10417.
    >> Share

  245. VAUGHAN LE, Kanaji Y, Suvakov S, Parashuram S, et al
    Hypertensive Disorders of Pregnancy Increase the Risk for Myocardial Infarction: A Population-Based Study.
    J Am Coll Cardiol. 2024 Nov 2:S0735-1097(24)09771.
    >> Share

  246. HONIGBERG MC
    Classification of Myocardial Infarction in Women With Hypertensive Disorders of Pregnancy.
    J Am Coll Cardiol. 2024 Nov 1:S0735-1097(24)09773.
    >> Share

    October 2024
  247. CHEN Z, Vieira de Oliveira Salerno PR, Dazard JE, Kumar Sirasapalli S, et al
    AI-Facilitated Assessment of Built Environment Using Neighborhood Satellite Imagery and Cardiovascular Risk.
    J Am Coll Cardiol. 2024;84:1733-1744.
    >> Share

  248. WASFY JH, Januzzi JL Jr
    The Long Pathway to Improving Clinical Decisions With Better Risk Markers: Recurrent Thrombosis After Myocardial Infarction.
    J Am Coll Cardiol. 2024;84:1730-1732.
    >> Share

  249. SCHNEIDER DJ, McMahon SR, Angiolillo DJ, Fanaroff A, et al
    Platelet FcgammaRIIa as a Marker of Cardiovascular Risk After Myocardial Infarction.
    J Am Coll Cardiol. 2024;84:1721-1729.
    >> Share

  250. GALLI M, Cortellini G, Occhipinti G, Rossini R, et al
    Aspirin Hypersensitivity in Patients With Atherosclerotic Cardiovascular Disease.
    J Am Coll Cardiol. 2024;84:1748-1766.
    >> Share

  251. JAMES P
    Using Artificial Intelligence to Derive Environmental Drivers of Cardiovascular Risk: Is it Intelligent Enough?
    J Am Coll Cardiol. 2024;84:1745-1747.
    >> Share

  252. SAKAI K, Shin D, Singh M, Malik S, et al
    Diagnostic Performance and Clinical Impact of Photon-Counting Detector Computed Tomography in Coronary Artery Disease.
    J Am Coll Cardiol. 2024 Oct 23:S0735-1097(24)09956.
    >> Share

  253. MARINACCI LX, Zheng Z, Mein S, Wadhera RK, et al
    Rural-Urban Differences in Cardiovascular Mortality in the United States, 2010-2022.
    J Am Coll Cardiol. 2024 Oct 23:S0735-1097(24)09779.
    >> Share

  254. CAVENDER MA
    Optimizing Outcomes in ST-Segment Elevation Myocardial Infarction: Is Prolonged Infusion of Bivalirudin Part of the Solution?
    J Am Coll Cardiol. 2024;84:1525-1527.
    >> Share

  255. STONE GW, Valgimigli M, Erlinge D, Han Y, et al
    Bivalirudin vs Heparin Anticoagulation in STEMI: Confirmation of the BRIGHT-4 Results.
    J Am Coll Cardiol. 2024;84:1512-1524.
    >> Share

  256. FUSTER V, Garcia-Alvarez A, Devesa A, Mass V, et al
    Influence of Subclinical Atherosclerosis Burden and Progression on Mortality.
    J Am Coll Cardiol. 2024;84:1391-1403.
    >> Share

  257. YOU SC, Yao X, Bikdeli B, Spatz ES, et al
    Embracing Change: Human-Centered Cardiovascular Medicine in the Era of AI.
    J Am Coll Cardiol. 2024;84:1495-1497.
    >> Share

  258. BJORNSON E, Adiels M, Gummesson A, Taskinen MR, et al
    Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations With Inflammation, and Implications for Risk Assessment Using Non-HDL Cholesterol.
    J Am Coll Cardiol. 2024;84:1328-1338.
    >> Share

  259. MIERES JH, Douglass PL
    RESPONSE: DEI in the CV Workforce: Foundational for Cardiovascular Care and Critical for Improving Outcomes.
    J Am Coll Cardiol. 2024;84:1370-1371.
    >> Share

  260. ZOCCALI C, Mallamaci F
    Can the Excess Cardiovascular Risk Caused by Chronic Kidney Disease Be Canceled Out?
    J Am Coll Cardiol. 2024;84:1325-1327.
    >> Share

  261. GENG T, Xu W, Gao H, Zhang J, et al
    Relationship Between Control of Cardiovascular Risk Factors and Chronic Kidney Disease Progression, Cardiovascular Disease Events, and Mortality in Chinese Adults.
    J Am Coll Cardiol. 2024;84:1313-1324.
    >> Share

    September 2024
  262. BIGA C
    Our Collective Role in Cardiovascular Advocacy.
    J Am Coll Cardiol. 2024 Sep 29:S0735-1097(24)08458.
    >> Share

  263. JAVAHERI S, Javaheri S, Gozal D, Campos-Rodriguez F, et al
    Treatment of OSA and its Impact on Cardiovascular Disease, Part 2: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2024;84:1224-1240.
    >> Share

  264. JAVAHERI S, Javaheri S, Somers VK, Gozal D, et al
    Interactions of Obstructive Sleep Apnea With the Pathophysiology of Cardiovascular Disease, Part 1: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2024;84:1208-1223.
    >> Share

  265. BHAVE NM, Cibotti-Sun M, Moore MM
    2024 Perioperative Cardiovascular Management for Noncardiac Surgery Guideline-at-a-Glance.
    J Am Coll Cardiol. 2024 Sep 23:S0735-1097(24)08173.
    >> Share

  266. THOMPSON A, Fleischmann KE, Smilowitz NR, de Las Fuentes L, et al
    2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    J Am Coll Cardiol. 2024 Sep 23:S0735-1097(24)07611.
    >> Share

  267. AL-KINDI S, Nasir K, Rajagopalan S
    Elemental Risk: Role of Metals in Cardiovascular Disease Risk.
    J Am Coll Cardiol. 2024 Sep 12:S0735-1097(24)07985.
    >> Share

  268. MCGRAW KE, Schilling K, Glabonjat RA, Galvez-Fernandez M, et al
    Urinary Metal Levels and Coronary Artery Calcification: Longitudinal Evidence in the Multi-Ethnic Study of Atherosclerosis.
    J Am Coll Cardiol. 2024 Sep 12:S0735-1097(24)07961.
    >> Share

  269. ZAHGER D, Schwartz GG, Du W, Szarek M, et al
    Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome.
    J Am Coll Cardiol. 2024;84:994-1006.
    >> Share

  270. TOTH PP
    Triglycerides and Cardiovascular Risk: Getting to the Heart of the Matter.
    J Am Coll Cardiol. 2024;84:1007-1009.
    >> Share

  271. YANG E, Bhatt DL, Atwater B
    Bleeding and Thrombosis in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2024;84:886-888.
    >> Share

  272. BERWANGER O, Wojdyla DM, Fanaroff AC, Budaj A, et al
    Antithrombotic Strategies in Atrial Fibrillation After ACS and/or PCI: A 4-Way Comparison From AUGUSTUS.
    J Am Coll Cardiol. 2024;84:875-885.
    >> Share

  273. EVERETT BM, Wexler DJ
    Finding Truth in Observational and Interventional Studies in Diabetes and Cardiovascular Disease.
    J Am Coll Cardiol. 2024;84:918-920.
    >> Share

  274. KHERA R, Aminorroaya A, Dhingra LS, Thangaraj PM, et al
    Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DM.
    J Am Coll Cardiol. 2024;84:904-917.
    >> Share

    August 2024
  275. VERMA S, Colhoun HM, Dicker D, Hovingh GK, et al
    Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT): Outcomes by Sex.
    J Am Coll Cardiol. 2024 Aug 29:S0735-1097(24)08194.
    >> Share

  276. KANG DY, Lee SH, Lee SW, Lee CH, et al
    Aspirin Monotherapy vs No Antiplatelet Therapy in Stable Patients With Coronary Stents Undergoing Low-to-Intermediate Risk Noncardiac Surgery.
    J Am Coll Cardiol. 2024 Aug 29:S0735-1097(24)08196.
    >> Share

  277. HAMMERSLEY DJ, Zegard A, Androulakis E, Jones RE, et al
    Arrhythmic Risk Stratification by Cardiovascular Magnetic Resonance Imaging in Patients With Nonischemic Cardiomyopathy.
    J Am Coll Cardiol. 2024 Aug 29:S0735-1097(24)08109.
    >> Share

  278. MANUBOLU VS, Lakshmanan S, Kinninger A, Ahmad K, et al
    Effect of Semaglutide on Epicardial Adipose Tissue in Type 2 Diabetes: Insights From the STOP (Semaglutide Treatment effect On coronary atherosclerosis Progression) Randomized Trial.
    J Am Coll Cardiol. 2024;84:865-867.
    >> Share

  279. NEUEN BL, Ostrominski JW, Claggett B, Beldhuis IE, et al
    Bidirectional Relationship Between Kidney Disease Progression and Cardiovascular Events in Type 2 Diabetes.
    J Am Coll Cardiol. 2024 Aug 26:S0735-1097(24)08155.
    >> Share

  280. COCCO M, Campo G, Guiducci V, Casella G, et al
    Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction With or Without ST-Segment Elevation.
    J Am Coll Cardiol. 2024 Aug 25:S0735-1097(24)07984.
    >> Share

  281. KRUMHOLZ HM, Geraldes F, Wilson C, Horton R, et al
    The Lancet-JACC Collaboration: Advancing Cardiovascular Health.
    J Am Coll Cardiol. 2024 Aug 24:S0735-1097(24)08240.
    >> Share

  282. AHMAD Y, Reddy RK, Mehta SR
    Myocardial Infarction and Multivessel Disease: Completing the Story.
    J Am Coll Cardiol. 2024 Aug 22:S0735-1097(24)08157.
    >> Share

  283. ANGIOLILLO DJ
    Management of Antiplatelet Therapy After Coronary Stenting in Patients Requiring Non-Cardiac Surgery.
    J Am Coll Cardiol. 2024 Aug 22:S0735-1097(24)08251.
    >> Share

  284. DOHERTY JU, Daugherty SL, Kort S, London MJ, et al
    ACC/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2024 Appropriate Use Criteria for Multimodality Imaging in Cardiovascular Evaluation of Patients Undergoing Nonemergent, Noncardiac Surgery.
    J Am Coll Cardiol. 2024 Aug 21:S0735-1097(24)07963.
    >> Share

  285. HINKOV H, Greve D, Lee CB, Klein C, et al
    Combined Surgical and Percutaneous Management of Circumflex Artery Occlusion After Minimally Invasive Mitral Valve Repair.
    J Am Coll Cardiol. 2024;84:766-770.
    >> Share

  286. MONTONE RA, Rinaldi R, Niccoli G, Ando G, et al
    Optimizing Management of Stable Angina: A Patient-Centered Approach Integrating Revascularization, Medical Therapy, and Lifestyle Interventions.
    J Am Coll Cardiol. 2024;84:744-760.
    >> Share

  287. CLERICO A, Aimo A, Passino C
    Point-of-Care High-Sensitivity Troponin Testing in the Emergency Department: The Way of the Future?
    J Am Coll Cardiol. 2024;84:741-743.
    >> Share

  288. KOECHLIN L, Boeddinghaus J, Lopez-Ayala P, Reber C, et al
    Clinical and Analytical Performance of a Novel Point-of-Care High-Sensitivity Cardiac Troponin I Assay.
    J Am Coll Cardiol. 2024;84:726-740.
    >> Share

  289. NEUEN BL, Solomon SD
    Kidney and Cardiovascular Outcomes With SGLT2 Inhibitors and/or GLP-1 Receptor Agonists in Type 2 Diabetes.
    J Am Coll Cardiol. 2024;84:709-711.
    >> Share

  290. EDMONSTON D, Mulder H, Lydon E, Chiswell K, et al
    Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 Diabetes.
    J Am Coll Cardiol. 2024;84:696-708.
    >> Share

  291. AHMAD T, Desai NR, Tabtabai S
    Cardiovascular Care in the United States: Penny Wise and Pound Foolish.
    J Am Coll Cardiol. 2024;84:694-695.
    >> Share

  292. GIBSON CM, Chi G, Duffy D, Bahit MC, et al
    ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction: Insights From the AEGIS-II Trial.
    J Am Coll Cardiol. 2024 Aug 20:S0735-1097(24)08038.
    >> Share

  293. NI W, Stafoggia M, Zhang S, Ljungman P, et al
    Short-Term Effects of Lower Air Temperature and Cold Spells on Myocardial Infarction Hospitalizations in Sweden.
    J Am Coll Cardiol. 2024 Aug 19:S0735-1097(24)07842.
    >> Share

  294. CHADALAVADA S, Fung K, Rauseo E, Lee AM, et al
    Myocardial Strain Measured by Cardiac Magnetic Resonance Predicts Cardiovascular Morbidity and Death.
    J Am Coll Cardiol. 2024;84:648-659.
    >> Share

  295. CHEN K, Nasir K
    Balancing the Climate Equation: The Unseen Cardiovascular Threat of Cold Spells in a Warming World.
    J Am Coll Cardiol. 2024 Aug 13:S0735-1097(24)07958.
    >> Share

  296. PATEL RB
    Mechanistic Insights of SGLT2 Inhibition in Heart Failure Through Proteomics: Appreciating the Cardiovascular-Kidney Connection.
    J Am Coll Cardiol. 2024 Aug 12:S0735-1097(24)08016.
    >> Share

  297. MAHENDIRAN T, Bertolone D, Viscusi MM, Gallinoro E, et al
    The Influence of Epicardial Resistance on Microvascular Resistance Reserve.
    J Am Coll Cardiol. 2024;84:512-521.
    >> Share

  298. INZUCCHI SE, Arai AE
    Inquiries Into the Mechanisms by Which GLP-1 Receptor Agonists Reduce Cardiovascular Risk in Diabetes.
    J Am Coll Cardiol. 2024;84:558-560.
    >> Share

    July 2024
  299. CARNEY RM, Freedland KE, Rich MW
    Treating Depression to Improve Survival in Coronary Heart Disease: What Have We Learned?
    J Am Coll Cardiol. 2024;84:482-489.
    >> Share

  300. NANNA MG, Mangalesh S
    Searching for Meaning: Refining Troponin Thresholds to Align Risks Between Spontaneous and Procedural Myocardial Infarction.
    J Am Coll Cardiol. 2024;84:478-481.
    >> Share

  301. SPIRITO A, Sartori S, Koshy AN, Feng Y, et al
    Mortality After Procedural or Spontaneous Myocardial Infarction.
    J Am Coll Cardiol. 2024;84:467-477.
    >> Share

  302. PLEIN S, Bulluck H
    Prognostic Significance of Peri-Infarct Ischemia: More Than the Sum of Its Parts.
    J Am Coll Cardiol. 2024;84:430-433.
    >> Share

  303. BERNHARD B, Ge Y, Antiochos P, Heydari B, et al
    Association of Adverse Clinical Outcomes With Peri-Infarct Ischemia Detected by Stress Cardiac Magnetic Imaging.
    J Am Coll Cardiol. 2024;84:417-429.
    >> Share

  304. SONG WL, Ramirez VN, Wells QS
    Revealing the Potential of Lipidomics: Improving Cardiovascular Risk Assessment.
    J Am Coll Cardiol. 2024;84:447-449.
    >> Share

  305. WU J, Giles C, Dakic A, Beyene HB, et al
    Lipidomic Risk Score to Enhance Cardiovascular Risk Stratification for Primary Prevention.
    J Am Coll Cardiol. 2024;84:434-446.
    >> Share

  306. EZAD SM, McEntegart M, Dodd M, Didagelos M, et al
    Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy.
    J Am Coll Cardiol. 2024;84:340-350.
    >> Share

  307. BANNING AP
    Revascularization Strategies in Patients With MI and MVD: Have We Got the Answers?
    J Am Coll Cardiol. 2024;84:295-297.
    >> Share

  308. REDDY RK, Howard JP, Jamil Y, Madhavan MV, et al
    Percutaneous Coronary Revascularization Strategies After Myocardial Infarction: A Systematic Review and Network Meta-Analysis.
    J Am Coll Cardiol. 2024;84:276-294.
    >> Share

  309. BABER U
    Stent Failure After Percutaneous Coronary Intervention in Diabetes Mellitus: Does Glycemic Control Matter?
    J Am Coll Cardiol. 2024;84:273-275.
    >> Share

  310. EBONG IA, Quesada O, Fonkoue IT, Mattina D, et al
    The Role of Psychosocial Stress on Cardiovascular Disease in Women: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2024;84:298-314.
    >> Share

  311. CARVALHO MF, Cabral M, Goncalves C, Graca Santos L, et al
    An Intramyocardial Mass Mimicking ST-Segment Elevation Myocardial Infarct at Presentation.
    J Am Coll Cardiol. 2024;84:229-231.
    >> Share

  312. SANDNER S, Redfors B, An KR, Harik L, et al
    Coronary Artery Bypass Graft Failure in Women: Incidence and Clinical Implications.
    J Am Coll Cardiol. 2024;84:182-191.
    >> Share

  313. ARNOLD N, Blaum C, Gossling A, Brunner FJ, et al
    Impact of Lipoprotein(a) Level on Low-Density Lipoprotein Cholesterol- or Apolipoprotein B-Related Risk of Coronary Heart Disease.
    J Am Coll Cardiol. 2024;84:165-177.
    >> Share

  314. LINCOFF AM, Ray KK, Sasiela WJ, Haddad T, et al
    Comparative Cardiovascular Benefits of Bempedoic Acid and Statin Drugs.
    J Am Coll Cardiol. 2024;84:152-162.
    >> Share

  315. KHERA R, Oikonomou EK, Nadkarni GN, Morley JR, et al
    Transforming Cardiovascular Care With Artificial Intelligence: From Discovery to Practice: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2024;84:97-114.
    >> Share

  316. PACKER M
    Lessons for Cardiovascular Clinical Investigators: The Tumultuous 2,500-Year Journey of Physicians Who Ignited Our Fire.
    J Am Coll Cardiol. 2024;84:78-96.
    >> Share

  317. WARRAICH HJ, Califf RM
    The FDA and the Cardiovascular Community.
    J Am Coll Cardiol. 2024;84:124-129.
    >> Share

    June 2024
  318. MORTENSEN MB, Jensen JM, Ronnow Sand NP, Kragholm K, et al
    Association of Autoimmune Diseases With Coronary Atherosclerosis Severity and Ischemic Events.
    J Am Coll Cardiol. 2024;83:2643-2654.
    >> Share

  319. ALMENDRO-DELIA M, Hernandez-Meneses B, Padilla-Rodriguez G, Blanco-Ponce E, et al
    Timing of P2Y(12) Inhibitor Administration in Patients With STEMI Undergoing Primary PCI.
    J Am Coll Cardiol. 2024;83:2629-2639.
    >> Share

  320. WEISFELDT ML, Sisson SD
    Evaluating Long-Term Care After ST-Segment Elevation Myocardial Infarction With a Population-Based Comprehensive Medical Record.
    J Am Coll Cardiol. 2024;83:2626-2628.
    >> Share

  321. THRANE PG, Olesen KKW, Thim T, Gyldenkerne C, et al
    10-Year Mortality After ST-Segment Elevation Myocardial Infarction Compared to the General Population.
    J Am Coll Cardiol. 2024;83:2615-2625.
    >> Share

  322. CHAN YH, Zhao JV, Au Yeung SL, Wong YK, et al
    Early Renal Dysfunction in Middle-Aged Adults Predicts Fatal and Nonfatal Cardiovascular Events.
    J Am Coll Cardiol. 2024;83:2711-2713.
    >> Share

  323. VERVOORT D, Wang R, Li G, Filbey L, et al
    Addressing the Global Burden of Cardiovascular Disease in Women: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2024;83:2690-2707.
    >> Share

  324. A FRY ET
    Private Equity in Cardiovascular Practice: Solution or Symptom.
    J Am Coll Cardiol. 2024 Jun 21:S0735-1097(24)07610.
    >> Share

  325. MENSAH GA, Myers T, Schmelzer R Jr, Spaeth S, et al
    Turning Data Into Action: The JACC Global Burden of Cardiovascular Diseases and Risks Interactive Tool and Resources.
    J Am Coll Cardiol. 2024;83:2610-2613.
    >> Share

  326. WALSH MN, Lindenfeld J
    Gender Diversity in Cardiovascular Journal Authorship: So Much Time, So Little Progress.
    J Am Coll Cardiol. 2024;83:2469-2471.
    >> Share

  327. GOEL R, Sartori S, Vogel B, Okoli K, et al
    Geographic Mapping of Gender Disparities in Authorship of Cardiovascular Literature.
    J Am Coll Cardiol. 2024;83:2458-2468.
    >> Share

  328. AMINIAN A, Wang L, Al Jabri A, Wilson R, et al
    Adverse Cardiovascular Outcomes in Patients with Obstructive Sleep Apnea and Obesity: Metabolic Surgery versus Usual Care.
    J Am Coll Cardiol. 2024 Jun 13:S0735-1097(24)07559.
    >> Share

  329. MIERES JH, Kuvin JT, Roswell RO
    Cardiovascular Health, Juneteenth 2024: Are We Thriving Together or Not?
    J Am Coll Cardiol. 2024 Jun 12:S0735-1097(24)07555.
    >> Share

  330. ARUN AS, Sawano M, Lu Y, Warner F, et al
    Excess Cardiovascular Mortality Among Black Americans 2000-2022: A JACC Report Card.
    J Am Coll Cardiol. 2024 Jun 12:S0735-1097(24)07546.
    >> Share

  331. JOHANNESEN CDL, Langsted A, Nordestgaard BG, Mortensen MB, et al
    Excess Apolipoprotein B and Cardiovascular Risk in Women and Men.
    J Am Coll Cardiol. 2024;83:2262-2273.
    >> Share

  332. ITCHHAPORIA D
    Transforming Care in ACS Patients: A Potential Digital Revolution in Post-Percutaneous Coronary Intervention Care.
    J Am Coll Cardiol. 2024;83:2260-2261.
    >> Share

  333. KOCHAR A, Gattani R, Vaduganathan M
    Patient Selection Is the Key to EMPACTing Development of Heart Failure After Myocardial Infarction.
    J Am Coll Cardiol. 2024;83:2247-2249.
    >> Share

  334. KHATANA SAM
    Climate Change and Cardiovascular Mortality: Will Fewer Cold Days Balance Out More Hot Days?
    J Am Coll Cardiol. 2024;83:2288-2290.
    >> Share

  335. HUNDESSA S, Huang W, Zhao Q, Wu Y, et al
    Global and Regional Cardiovascular Mortality Attributable to Nonoptimal Temperatures Over Time.
    J Am Coll Cardiol. 2024;83:2276-2287.
    >> Share

  336. REDFORS B, Gaudino MFL
    Reply: Initial Medical Therapy for Stable Coronary Artery Disease: Until Death Do Us Part.
    J Am Coll Cardiol. 2024;83:e219.
    >> Share

  337. FERREIRA RM, Salis LHA, de Souza E Silva NA
    Initial Medical Therapy for Stable Coronary Artery Disease: Until Death Do Us Part.
    J Am Coll Cardiol. 2024;83:e217.
    >> Share

  338. WELT FGP, Batchelor W, Spears JR, Penna C, et al
    Reperfusion Injury in Patients With Acute Myocardial Infarction: JACC Scientific Statement.
    J Am Coll Cardiol. 2024;83:2196-2213.
    >> Share

  339. FAYAD ZA, Robson PM, Fuster V
    Rethinking Heart Attack Prevention: The Myth of the "Vulnerable Plaque" and Reality of Patient Risk.
    J Am Coll Cardiol. 2024;83:2145-2147.
    >> Share

  340. WANG KL, Balmforth C, Meah MN, Daghem M, et al
    Coronary Atherosclerotic Plaque Activity and Risk of Myocardial Infarction.
    J Am Coll Cardiol. 2024;83:2135-2144.
    >> Share

  341. CHERTOW GM
    Revisiting a "Paradigm" in Cardiovascular and Kidney Disease.
    J Am Coll Cardiol. 2024;83:2160-2162.
    >> Share

    May 2024
  342. KANG DY, Ahn JM, Park SJ, Park DW, et al
    Reply: Intravascular Imaging for Complex Coronary Intervention.
    J Am Coll Cardiol. 2024;83:e209.
    >> Share

  343. GUNER A, Akturk IF, Cizgici AY, Uzun F, et al
    Intravascular Imaging for Complex Coronary Intervention.
    J Am Coll Cardiol. 2024;83:e207.
    >> Share

  344. DHARMAKUMAR R, Kumar A
    Hemorrhagic Myocardial Infarction: Light After 50 Years in the Tunnel.
    J Am Coll Cardiol. 2024;83:2063-2065.
    >> Share

  345. LECHNER I, Reindl M, Stiermaier T, Tiller C, et al
    Clinical Outcomes Associated With Various Microvascular Injury Patterns Identified by CMR After STEMI.
    J Am Coll Cardiol. 2024;83:2052-2062.
    >> Share

  346. MINER SES, Blair JA, McCarthy MC, Nield LE, et al
    The Complex and Incomplete Relationship Between Exercise Stress Testing and Coronary Microvascular Dysfunction.
    J Am Coll Cardiol. 2024;83:e193-e194.
    >> Share

  347. DIMITRIADIS K, Pyrpyris N, Tsioufis K
    Exercise Electrocardiographic Stress Test for Diagnosing Coronary Microvascular Dysfunction: Tale as Old as Time?
    J Am Coll Cardiol. 2024;83:e189.
    >> Share

  348. SINHA A, Rahman H, Perera D
    Reply: Rethinking False Positive Exercise Electrocardiographic Stress Tests by Assessing Coronary Microvascular Function.
    J Am Coll Cardiol. 2024;83:e195-e196.
    >> Share

  349. HUNG CL, Yang NI, Chiang CE
    Cardiovascular Risk Stratification by LV Size Among AF Population: Smaller Is Not Always Better.
    J Am Coll Cardiol. 2024;83:1970-1972.
    >> Share

  350. LI M, Ren L, He L, Lai Y, et al
    Small Left Ventricle in Patients With Atrial Fibrillation Is Associated With Increased Cardiovascular Risk.
    J Am Coll Cardiol. 2024;83:1957-1969.
    >> Share

  351. SHAPIRO MD, German CA
    Early Inclisiran Use in Atherosclerotic Cardiovascular Disease: Overcoming Therapeutic Inertia.
    J Am Coll Cardiol. 2024;83:1953-1956.
    >> Share

  352. LORUSSO R, Matteucci M, Lerakis S, Ronco D, et al
    Postmyocardial Infarction Ventricular Aneurysm: JACC Focus Seminar 5/5.
    J Am Coll Cardiol. 2024;83:1917-1935.
    >> Share

  353. LORUSSO R, Cubeddu RJ, Matteucci M, Ronco D, et al
    Ventricular Pseudoaneurysm and Free Wall Rupture After Acute Myocardial Infarction: JACC Focus Seminar 4/5.
    J Am Coll Cardiol. 2024;83:1902-1916.
    >> Share

  354. CUBEDDU RJ, Lorusso R, Ronco D, Matteucci M, et al
    Ventricular Septal Rupture After Myocardial Infarction: JACC Focus Seminar 3/5.
    J Am Coll Cardiol. 2024;83:1886-1901.
    >> Share

  355. APPLE FS
    Early Safe Rule Out Using High-Sensitivity Cardiac Troponin: The Role of Sex.
    J Am Coll Cardiol. 2024;83:1867-1869.
    >> Share

  356. ALEXANDER GC, Moore TJ, Brass EP
    Long-Term Cardiovascular Risks of Psychostimulant Drugs for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD).
    J Am Coll Cardiol. 2024;83:1883-1885.
    >> Share

  357. HOLT A, Strange JE, Rasmussen PV, Nouhravesh N, et al
    Long-Term Cardiovascular Risk Associated With Treatment of Attention-Deficit/Hyperactivity Disorder in Adults.
    J Am Coll Cardiol. 2024;83:1870-1882.
    >> Share

  358. GUSEH JS 2ND, Januzzi JL Jr
    The Hidden Cardiovascular Crisis Among Former NFL Athletes: After the HUDDLE.
    J Am Coll Cardiol. 2024;83:1838-1840.
    >> Share

  359. SIMADER FA, Rajkumar CA, Foley MJ, Ahmed-Jushuf F, et al
    Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery Disease.
    J Am Coll Cardiol. 2024 May 10:S0735-1097(24)06948.
    >> Share

  360. OSTROMINSKI JW, Claggett BL, Miao ZM, Mc Causland FR, et al
    Cardiovascular-Kidney-Metabolic Overlap in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Trial-Level Analysis.
    J Am Coll Cardiol. 2024 May 9:S0735-1097(24)07204.
    >> Share

  361. RAJKUMAR CA, Foley MJ, Ahmed-Jushuf F, Simader FA, et al
    N-of-1 Trial of Angina Verification Before Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2024 May 8:S0735-1097(24)06824.
    >> Share

  362. ESTEVEZ-LOUREIRO R, Lorusso R, Taramasso M, Torregrossa G, et al
    Management of Severe Mitral Regurgitation in Patients With Acute Myocardial Infarction: JACC Focus Seminar 2/5.
    J Am Coll Cardiol. 2024;83:1799-1817.
    >> Share

  363. GOLDSTEIN JA, Lerakis S, Moreno PR
    Right Ventricular Myocardial Infarction-A Tale of Two Ventricles: JACC Focus Seminar 1/5.
    J Am Coll Cardiol. 2024;83:1779-1798.
    >> Share

  364. BLANKSTEIN R, Shiyovich A
    Can Plaque Imaging Improve Risk Assessment Among Individuals With Elevated Lp(a)?
    J Am Coll Cardiol. 2024;83:1756-1759.
    >> Share

  365. YU MM, Wang ML, Wang JJ, Lin BL, et al
    Association of Lipoprotein(a) Levels With Myocardial Infarction in Patients With Low-Attenuation Plaque.
    J Am Coll Cardiol. 2024;83:1743-1755.
    >> Share

  366. NATARAJAN P, Bellomo TR
    Clonal Hematopoiesis Among Patients With Asymptomatic Carotid Stenosis Compounds Risk of Cardiovascular Death.
    J Am Coll Cardiol. 2024;83:1728-1730.
    >> Share

  367. JAGER R, Hoke M, Mayer FJ, Boden S, et al
    Combined Effects of Clonal Hematopoiesis and Carotid Stenosis on Cardiovascular Mortality.
    J Am Coll Cardiol. 2024;83:1717-1727.
    >> Share

  368. SANTOS-PARDO I, Andersson Franko M, Lagerqvist B, Ritsinger V, et al
    Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus.
    J Am Coll Cardiol. 2024 May 7:S0735-1097(24)06933.
    >> Share

  369. ALI ZA, Landmesser U, Maehara A, Shin D, et al
    OCT-Guided versus Angiography-Guided Coronary Stent Implantation in Complex Lesions: An ILUMIEN IV Substudy.
    J Am Coll Cardiol. 2024 May 6:S0735-1097(24)07085.
    >> Share

  370. EERDEKENS R, El Farissi M, De Maria GL, van Royen N, et al
    Prognostic Value of Microvascular Resistance Reserve After Percutaneous Coronary Intervention in Patients With Myocardial Infarction.
    J Am Coll Cardiol. 2024 May 3:S0735-1097(24)06759.
    >> Share

    April 2024
  371. PICCOLO R, Angellotti D, Simonetti F, Leone A, et al
    Evidence Supporting Criteria for Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2024;83:1713-1715.
    >> Share

  372. QUESADA O, Crousillat D, Rodriguez F, Bravo-Jaimes K, et al
    Cardiovascular Disease in Hispanic Women: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024;83:1702-1712.
    >> Share

  373. BOULESTREAU R, Spiewak M, Januszewicz A, Kreutz R, et al
    Malignant Hypertension:A Systemic Cardiovascular Disease: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024;83:1688-1701.
    >> Share

  374. HUANG T
    Low Delta Wave Activity During Sleep Promotes Cardiovascular Disease Risk: What's Next?
    J Am Coll Cardiol. 2024;83:1685-1687.
    >> Share

  375. PARSA S, Saleh A, Raygor V, Hoeting N, et al
    Measurement and Application of Incidentally Detected Coronary Calcium: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024;83:1557-1567.
    >> Share

  376. ZERN EK, Gupta T, Ryoo Ali HJ, Thakker P, et al
    A Leadership Program to Support Career Development of Cardiovascular Chief Fellows.
    J Am Coll Cardiol. 2024;83:1623-1625.
    >> Share

  377. ELKIND MSV
    How Physical Activity Lowers Cardiovascular Risk: Exercise Can Change Your Mind.
    J Am Coll Cardiol. 2024;83:1554-1556.
    >> Share

  378. ZUREIGAT H, Osborne MT, Abohashem S, Mezue K, et al
    Effect of Stress-Related Neural Pathways on the Cardiovascular Benefit of Physical Activity.
    J Am Coll Cardiol. 2024;83:1543-1553.
    >> Share

  379. WONG ND, Fan W, Hu X, Ballantyne C, et al
    Lipoprotein(a) and Long-Term Cardiovascular Risk in a Multi-Ethnic Pooled Prospective Cohort.
    J Am Coll Cardiol. 2024;83:1511-1525.
    >> Share

  380. BOROVAC JA
    Unlocking the Gates of ISCHEMIA: Moving Toward Personalized Angina Management for Chronic Coronary Syndrome.
    J Am Coll Cardiol. 2024;83:1367-1369.
    >> Share

  381. ARNOLD SV, Jones PG, Maron DJ, Cohen DJ, et al
    Variation in Health Status With Invasive vs Conservative Management of Chronic Coronary Disease.
    J Am Coll Cardiol. 2024;83:1353-1366.
    >> Share

  382. KOREN MJ, Rodriguez F, East C, Toth PP, et al
    An "Inclisiran First" Strategy vs Usual Care in Patients With Atherosclerotic Cardiovascular Disease.
    J Am Coll Cardiol. 2024 Apr 7:S0735-1097(24)06624.
    >> Share

  383. SCHNEIDER PA, Olin JW
    Paclitaxel-Mortality Risk Hypothesis Debunked: What We Learned and How It Will Change Future Clinical Trials.
    J Am Coll Cardiol. 2024;83:1222-1224.
    >> Share

  384. KONTOS MC, de Lemos JA
    Chest Pain in the Emergency Department: Chasing Perfection.
    J Am Coll Cardiol. 2024;83:1191-1193.
    >> Share

  385. MAHLER SA, Ashburn NP, Supples MW, Hashemian T, et al
    Validation of the ACC Expert Consensus Decision Pathway for Patients With Chest Pain.
    J Am Coll Cardiol. 2024;83:1181-1190.
    >> Share

  386. UDELL JA, Petrie MC, Jones WS, Anker SD, et al
    Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction.
    J Am Coll Cardiol. 2024 Apr 1:S0735-1097(24)06757.
    >> Share

  387. MINHAS AMK, Mathew RO, Sperling LS, Nambi V, et al
    Prevalence of the Cardiovascular-Kidney-Metabolic Syndrome in the United States.
    J Am Coll Cardiol. 2024 Apr 1:S0735-1097(24)00940.
    >> Share

    March 2024
  388. MORENO PR, Fuster V
    JACC Focus Seminar on Mechanical Complications of Acute Myocardial Infarction.
    J Am Coll Cardiol. 2024 Mar 30:S0735-1097(24)06820.
    >> Share

  389. AI S, Ye S, Li G, Leng Y, et al
    Association of Disrupted Delta Wave Activity During Sleep With Long-Term Cardiovascular Disease and Mortality.
    J Am Coll Cardiol. 2024 Mar 28:S0735-1097(24)00484.
    >> Share

  390. ALSHAHRANI NS, Hartley A, Howard J, Hajhosseiny R, et al
    Remote Acute Assessment of Cardiac Patients Post-Acute Coronary Syndrome (TELE-ACS): A Randomized Controlled Trial.
    J Am Coll Cardiol. 2024 Mar 28:S0735-1097(24)06709.
    >> Share

  391. ELIAS P, Jain S, Poterucha T, Randazzo M, et al
    Artificial Intelligence for Cardiovascular Care - Part 1: Advances: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024 Mar 26:S0735-1097(24)06742.
    >> Share

  392. JAIN S, Elias P, Poterucha T, Randazzo M, et al
    Artificial Intelligence in Cardiovascular Care - Part 2: Applications: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024 Mar 26:S0735-1097(24)06744.
    >> Share

  393. POVSIC TJ, Korjian S, Bahit MC, Chi G, et al
    Effect of CSL112 on Recurrent Myocardial Infarction and Cardiovascular Death: Insights from the AEGIS-II Trial.
    J Am Coll Cardiol. 2024 Mar 25:S0735-1097(24)06702.
    >> Share

  394. BATCHELOR WB, Damluji AA
    Rehospitalization After PCI vs CABG for Left Main Disease: Refocusing Our Lens.
    J Am Coll Cardiol. 2024;83:1082-1084.
    >> Share

  395. KOSMIDOU I, Shahim B, Dressler O, Redfors B, et al
    Incidence, Predictors, and Impact of Hospital Readmission After Revascularization for Left Main Coronary Disease.
    J Am Coll Cardiol. 2024;83:1073-1081.
    >> Share

  396. BRIGUORI C, Quintavalle C, Mariano E, D'Agostino A, et al
    Kidney Injury After Minimal Radiographic Contrast Administration in Patients With Acute Coronary Syndromes.
    J Am Coll Cardiol. 2024;83:1059-1069.
    >> Share

  397. SZAREK M, Bhatt DL, Miller M, Brinton EA, et al
    Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl.
    J Am Coll Cardiol. 2024 Mar 15:S0735-1097(24)00384.
    >> Share

  398. LI Z, Wereski R, Anand A, Lowry MT, et al
    Uniform or Sex-Specific Cardiac Troponin Thresholds to Rule-out Myocardial Infarction at Presentation.
    J Am Coll Cardiol. 2024 Mar 13:S0735-1097(24)00912.
    >> Share

  399. WILSON BH, Wu JC, Fang JC, Hurwitz JL, et al
    Modernizing Cardiovascular Medicine Board Certification: Leveraging Innovation and Strengthening Continuous Competency and Professional Growth.
    J Am Coll Cardiol. 2024 Mar 13:S0735-1097(24)00473.
    >> Share

  400. OKOH AK, Amponsah MKD, Cheffet-Walsh S, Patel M, et al
    Prevalence of Cardiovascular Disease and Risk Factors among National Football League Alumni and Family Members.
    J Am Coll Cardiol. 2024 Mar 12:S0735-1097(24)00988.
    >> Share

  401. BLAHA MJ, Bhatia HS
    Lipoprotein(a), Residual Cardiovascular Risk, and the Search for Targeted Therapy.
    J Am Coll Cardiol. 2024 Mar 9:S0735-1097(24)00944.
    >> Share

  402. HANSEN MK, Olesen KKW, Gyldenkerne C, Thrane PG, et al
    Eligibility for and Preventive Potential of Semaglutide in Overweight and Obese Patients With Myocardial Infarction.
    J Am Coll Cardiol. 2024;83:956-958.
    >> Share

  403. SCHWANN TA, Engelman DT
    Anemia and Sex Disparity in CABG Mortality: In Search of a Grand Unified Theory.
    J Am Coll Cardiol. 2024;83:929-931.
    >> Share

  404. MANN DL, Nicolas J, Claggett B, Miao ZM, et al
    Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI.
    J Am Coll Cardiol. 2024;83:904-914.
    >> Share

  405. MUKHERJEE D
    Is There a Role for Routine Stress Testing After Multivessel or Left Main PCI?
    J Am Coll Cardiol. 2024;83:901-903.
    >> Share

  406. LEE JM, Kim H, Park YS, Jo HH, et al
    Surveillance Stress Testing After Percutaneous Intervention for Patients With Multivessel or Left Main Coronary Disease.
    J Am Coll Cardiol. 2024;83:890-900.
    >> Share

  407. HARIK L, Habib RH, Dimagli A, Rahouma M, et al
    Intraoperative Anemia Mediates Sex Disparity in Operative Mortality After Coronary Artery Bypass Grafting.
    J Am Coll Cardiol. 2024;83:918-928.
    >> Share

  408. BERMAN AN, Biery DW, Besser SA, Singh A, et al
    Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients With or Without Baseline Atherosclerotic Cardiovascular Disease.
    J Am Coll Cardiol. 2024;83:873-886.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016